INTELLI CHECK INC
SB-2/A, 1999-11-15
PREPACKAGED SOFTWARE
Previous: INTELLI CHECK INC, 8-A12B, 1999-11-15
Next: SL GREEN REALTY CORP, 10-Q, 1999-11-15






    As filed with the Securities and Exchange Commission on November 15, 1999

                                                      Registration No. 333-87797
================================================================================


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   ----------

                                 Amendment No. 2
                                       to
                                    FORM SB-2
                             REGISTRATION STATEMENT
                                      Under
                           THE SECURITIES ACT OF 1933

                                   ----------

                               Intelli-Check, Inc.
                 (Name of small business issuer in its charter)


       Delaware                   11-3234779                      7372
  (State or other             (I.R.S. Employer      (Primary Standard Industrial
  jurisdiction of             Identification No.)     Classification Code No.)
  incorporation or
   organization)

                                 775 Park Avenue
                            Huntington, NY 11743-3976
                                (516) 421 - 2011
         (Address and telephone number of principal executive of offices
                        and principal place of business)

                                   ----------

                                Frank Mandelbaum
                                 775 Park Avenue
                            Huntington, NY 11743-3976
                                (516) 421 - 2011
        (Name, address and telephone number of agent for service process)

                                   ----------

                                   Copies to:
         Arnold N. Bressler, Esq                       James Martin Kaplan, Esq.
Milberg Weiss Bershad Hynes & Lerach LLP                Tenzer Greenblatt LLP
         One Pennsylvania Plaza                          405 Lexington Avenue
         New York, NY 10119-0165                          New York, NY 10174
           Tel: (212) 594-5300                           Tel: (212) 885-5000
           Fax: (212) 868-1229                            Fax: (212) 885-5001

                                   ----------

                Approximate date of proposed sale to the public:

   As soon as practicable after the Registration Statement becomes effective.

                                   ----------

      If any of these securities being registered on this form are to be offered
on a delayed or continuous  basis  pursuant to Rule 415 under the Securities Act
of 1933, check the following box. [X]

      If this Form is filed to register  additional  securities  for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list  the  Securities  Act  registration  statement  number  of the  earlier
effective registration number of the same offering. [ ]

      If this Form is a  post-effective  amendment filed pursuant to Rule 462(c)
under the  Securities  Act,  check the following box and list the Securities Act
registration  statement number of the earlier effective  registration  statement
for the same offering. [ ]

      If this Form is a  post-effective  amendment filed pursuant to Rule 462(d)
under the  Securities  Act,  check the following box and list the Securities Act
registration  statement number of the earlier effective  registration  statement
for the same offering. [ ]

      If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]

                                                          continued on next page

================================================================================

<PAGE>

continued from previous page


<TABLE>
<CAPTION>
                                        Calculation Of Registration Fee


===================================================================================================================
                                                                   Proposed         Proposed
                                                                    Maximum         Maximum          Amount of
Title of Each Class of Securities              Amount to be     Offering Price Aggregate Offering   Registration
  to be Registered                              Registered      per Security(1)     Price (1)          Fee(1)
- -------------------------------------------------------------------------------------------------------------------
<S>                                             <C>                   <C>           <C>                <C>
 Common Stock, $.001 par value                  1,175,000(2)          $7.50         $8,812,500         $2,449.88
- -------------------------------------------------------------------------------------------------------------------
 Underwriter's warrants (3)                       100,000             $.001            $100               (4)
===================================================================================================================
 Common Stock underlying
   Underwriter's Warrants                         100,000             $8.25          $825,000           $229.35
===================================================================================================================
 Total Registration Fee                                                                               $ 2,679.23
 Amount Previously Paid                                                                               $ 2,500.61
===================================================================================================================
 Amount Due                                                                                           $178.62(5)
===================================================================================================================
</TABLE>

(1)  Estimated  solely for the  purpose of  calculating  the  registration  fee
      pursuant to Rule 457(o) of the Securities Act.


(2)  Includes  150,000 shares which the  underwriter has the option to purchase
      to cover  over-allotments,  if any. Also includes 25,000 shares being sold
      by selling stockholders.


(3)  Represents warrants to be issued to the Underwriter. Pursuant to Rule 416,
      there is also being registered hereby such additional indeterminate number
      of  shares  of  Common  Stock as may  become  issuable  by  reason  of the
      anti-dilution provisions set forth in the Underwriter's Warrants.


(4) None pursuant to Section 457(g).


(5) Represents the amount due as a result of the increase in the offering price.

      The registrant hereby amends this  registration  statement on such date or
dates as may be necessary to delay its effective date until the registrant shall
file a further  amendment  which  specifically  states  that  this  registration
statement shall  thereafter  become effective in accordance with Section 8(a) of
the  Securities  Act of 1933 or until the  registration  statement  shall become
effective on such date as the Commission,  acting pursuant to said Section 8(a),
may determine.


================================================================================


<PAGE>


The  information in this  prospectus is not complete and may be changed.  We may
not sell  these  securities  until the  registration  statement  filed  with the
Securities and Exchange Commission is effective. This prospectus is not an offer
to  sell  these  securities  and it is not  soliciting  an  offer  to buy  these
securities in any state where the offeor sale is not permitted.


                 SUBJECT TO COMPLETION DATED NOVEMBER 15, 1999


                          [LOGO]INTELLI-CHECK(R), INC.



                        1,000,000 Shares of Common Stock
                                 $7.50 per share


      Intelli-Check,  Inc. is offering  1,000,000 shares of our common stock. We
are also  registering  25,000 shares of common stock for the benefit of existing
stockholders. Of these 25,000 shares, 15,000 will be issued upon the exercise of
warrants.  The  shares  to be  sold  by  existing  stockholders  are  not  being
underwritten  and we will not receive any  proceeds  from the shares sold by the
selling stockholders.

      This is our  initial  public  offering  and there  currently  is no public
market for our common  stock.  Application  has been made for  quotation  of our
common stock on the American Stock Exchange under the symbol "IDN".


      The net proceeds  from this offering are  estimated to be  $6,163,500.  We
plan to use the net proceeds to purchase terminals,  to repay indebtedness,  for
product  development,  sales and marketing  and for working  capital and general
corporate purposes.


                                   ----------

                  Investing in our common stock involves risks.


                     See "Risk Factors" beginning on page 5.


                                   ----------

      Neither the  Securities and Exchange  Commission nor any state  securities
commission has approved or  disapproved  of these  securities or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a
criminal offense.

                                   ----------


                                                     Offering Information
                                                ------------------------------
                                                 Per Share             Total
                                                 ---------          ----------
       Public offering price:                      $7.50            $7,500,000
       Underwriting discounts
          and commissions:                         $ .675           $  675,000
       Estimated offering expenses                 $ .6615          $  661,500
       Net proceeds to Intelli-Check               $6.1635          $6,163,500


                                   ----------

      We have  granted  the  underwriters  a 30-day  option to purchase up to an
additional  150,000  shares  of  common  stock  to  cover  over-allotments.  The
underwriters   are  offering  the  shares  on  a  firm  commitment   basis.  The
underwriters  expect to deliver  the  shares of common  stock to  purchasers  on
______________, 1999.


             GunnAllen                                    Starr Securities, Inc.
             Financial                                           [lOGO]




                         This prospectus is dated ___, 1999


<PAGE>




                 [PICTURES OF ID-CHECK PRODUCTS TO BE INCLUDED]


<PAGE>

- --------------------------------------------------------------------------------

                               PROSPECTUS SUMMARY


Our Business

      Intelli-Check  manufactures and markets an advanced document  verification
      system to enable a retailer to:


      o  determine the  customer's  age and the validity of the ID to detect and
         prevent  the  use of  fraudulent  identification  for the  purchase  of
         alcohol, tobacco and other age-restricted products;

      o  reduce the risk to the retailer of substantial monetary fines, criminal
         penalties  and  license  revocation  for  the  sale  of  age-restricted
         products to minors; and

      o  reduce check cashing, credit card and other types of fraud.



Our Location


      Our  principal   executive   offices  are  located  at  775  Park  Avenue,
Huntington,  New York 11743.  Our telephone  number is (516)  421-2011.  We were
originally  incorporated  in New York in October  1994.  In September  1999,  we
changed our state of incorporation to Delaware.

                                  THE OFFERING
Common stock offered
  by Intelli-Check .......    1,000,000 shares

Common stock to be
  outstanding after
  this offering ..........    6,271,152 shares. Our outstanding shares do not
                              include:

                              o  100,000 shares reserved for issuance upon
                                 exercise of the underwriters' warrants;

                              o  760,000 shares reserved for issuance upon
                                 exercise of options granted under our stock
                                 option plans, of which 392,500 are currently
                                 exercisable;

                              o  640,000  shares reserved for issuance upon
                                 exercise of options available for future grants
                                 under our stock option plans;

                              o  2,373,100 shares reserved for issuance upon
                                 exercise of non-plan options and warrants, all
                                 of which are currently exercisable; and

                              o  150,000  shares reserved for issuance in this
                                 offering to cover over-allotments, if any,  by
                                 the underwriters.

Use of proceeds ..........    We intend to use the net proceeds of this offering
                              for:

                              o  purchase of hardware;

                              o  repayment of indebtedness;

                              o  product development;

                              o  sales and marketing; and

                              o  working capital and general corporate purposes.

 Risk factors
                                 Investing in our common stock  involves a  high
                                 degree of risk and immediate and substantial
                                 dilution.

Proposed AMEX symbol .....    IDN

- --------------------------------------------------------------------------------


                                       3
<PAGE>

- --------------------------------------------------------------------------------

                         SUMMARY FINANCIAL INFORMATION

      The following  summary  financial  information as of December 31, 1998 and
1997,  and for the years  ended  December  31,  1998 and  December  31, 1997 are
derived from our audited financial statements.  The summary financial data as of
September 30, 1999 and for the nine months ended September 30, 1999 and 1998 are
derived from our unaudited financial statements.


<TABLE>
<CAPTION>
Statement of Operations Information:
                                                    Year Ended December 31      Nine Months Ended September 30
                                                ------------------------------  ------------------------------
                                                   1997              1998             1998          1999
                                                   ----              ----             ----          ----
                                                                                           (unaudited)
<S>                                              <C>               <C>             <C>           <C>
Sales                                            $    16,736       $    86,354     $   86,354    $       327
Cost of goods sold                                     4,343            22,074         22,074             55
Gross profit                                          12,393            64,280         64,280            272
Operating expenses                                 1,579,632         1,506,615        826,799      1,214,146
Net loss                                         $(1,604,296)      $(1,503,814)    $ (785,767)   $(1,249,458)
                                                 ===========       ===========     ==========    ===========

Net loss per common share basic and diluted      $     (0.46)      $     (0.36)    $    (0.19)   $     (0.26)
                                                 ===========       ===========     ==========    ===========

Common shares used in computing per
  share amounts:
Basic and diluted                                  3,505,638         4,208,003      4,162,553      4,841,483
                                                 ===========       ===========     ==========    ===========


<CAPTION>
Balance Sheet Information:

                                                                        September 30, 1999
                                                December 31,       ---------------------------
                                                   1998             Actual         As Adjusted
                                               ------------        --------        -----------
                                                                           (unaudited)
<S>                                                <C>             <C>              <C>
Cash                                               $ 159,600       $  762,239       $5,725,739
Working capital (deficit)                           (924,666)        (325,885)       4,637,615
Total assets                                         451,303        1,667,356        6,630,856
Total long-term debt                                   6,993           10,299           10,299
Total debt                                           113,153        1,227,942           27,942
Stockholders' (deficit) equity                      (657,570)         117,887        6,281,387
</TABLE>

      The as adjusted  information  presented  above gives effect to the sale of
1,000,000  shares offered by this  prospectus and the repayment of $1,200,000 in
secured promissory notes.

- --------------------------------------------------------------------------------


                                       4
<PAGE>

                                  RISK FACTORS

      The shares offered by this prospectus are speculative and involve a high
degree of risk. Each prospective investor should carefully consider the
following risk factors before making an investment decision.


      Because we have experienced losses and expect our expenses to increase, we
may not be able to achieve profitability.


      We have incurred operating losses since our inception. We had an
accumulated deficit of approximately $2.75 million at September 30, 1999. We
cannot assure you that our revenues will become significant or that we will ever
achieve profitable operations.


      If we are unable to obtain additional financing when needed, we will be
required to curtail our marketing and production plans and possibly cease
operations.

      Our capital requirements have been and will continue to be significant.
The net proceeds of the sale of the shares in this offering, together with our
available cash, are expected to continue to fund our projected operations at
least for the next twelve months. If we were to fail to attain positive cash
flow thereafter, we will be required to seek additional equity or debt financing
to fund the costs of our operations. We cannot assure you that additional
financing will be available to us when needed, on commercially reasonable terms,
or at all.

      Our products may not catch on.


      We cannot assure you that any of our products will gain market acceptance
or that our products will function to the satisfaction of our customers.


      We may have to reduce our prices to sell our product.

      We do not know whether we will be able to produce our product at a cost
that will be acceptable to potential purchasers. As a result, we may be required
to reduce our prices, which would have an adverse effect on our profit margins.

      A third party is seeking to invalidate our patent.


      The IdentiScan Company, LLC offers a product that electronically reads and
calculates age from a driver license. In August 1999, IdentiScan filed a
complaint against us which seeks to have the IdentiScan product declared
non-infringing on our patent and seeks to have our patent declared invalid. The
complaint does not seek monetary damages. We believe that our patent, to which
we hold clear title, is valid and fully enforceable. We intend to vigorously
defend it. We also believe IdentiScan's claim of non-infringement is without
merit. In October 1999, we made a motion to dismiss IdentiScan's claim. This
motion is currently pending. However, if our patent were to be declared invalid
or if our patent were to be otherwise limited, we believe it would have an
adverse effect on our business and future success because other companies,
including IdentiScan, might be able to use some or all of the technology covered
by our patent to develop and market products which will directly compete with
our products. Furthermore, if we were required to devote a significant portion
of the proceeds of this offering to defend our patent, we would have less money
available for other purposes.

      We currently rely on one hardware supplier to provide us with the
terminals to run our ID-Check software. Delays and inconsistencies in the
quality of the terminals could result in lost sales.

      If the supplier of our hardware terminals does not meet our delivery
requirements, we may have to seek an alternate supplier. While we believe they
would be available, we have not yet identified any alternate suppliers. Because
of the technological nature of our product, we may not be able to quickly
replace our current hardware supplier if that were necessary. Any delay in
securing a new source on satisfactory terms or within the time frame to meet our
sales goals could have a material adverse effect on our business. Additionally,
delays in production or inconsistencies in quality could result in our failure
to fulfill sales orders and the cancellation of potential orders, which could
damage our reputation.


                                       5
<PAGE>


      If governmental agencies were to stop cooperating with us, whether because
of privacy concerns or for any other reason, our ability to market our products
may be severely limited.

      Currently, a number of states and Canadian provinces which conform to the
guidelines established by standardization bodies cooperate with us by providing
sample driver licenses and identification cards so that we may program the
ID-Check terminal to read and analyze the encoded information found on the
driver licenses and identification cards. We cannot assure you that these
jurisdictions will continue to cooperate with us.

      Future government regulations restricting access to information
electronically stored on driver licenses could adversely affect our business.

      Our products can be used to capture information from driver licenses.
Currently, our customers are not legally restricted from using this information
for their own use. Because issues of personal privacy are currently a major
topic of public policy debate, it is possible that in the future merchants may
be restricted from capturing this information. In that event, we could
anticipate an adverse effect on our business.


      Our success depends on our two most senior officers.

      Our success will depend on our two most senior officers, Frank Mandelbaum,
our Chairman of the Board and Chief Executive Officer and Kevin Messina, our
President and Chief Technical Officer. The loss of the services of either of
them could materially and adversely affect us.


                           FORWARD-LOOKING STATEMENTS

      This prospectus contains forward-looking statements based on our current
expectations, assumptions, estimates and projections about Intelli-Check and our
industry. Our actual results could differ materially from those anticipated in
these forward-looking statements as a result of various factors, including all
the risks and uncertainties discussed in Risk Factors and elsewhere in this
prospectus. We do not undertake to update publicly any forward-looking
statements for any reason, even if new information becomes available or other
events occur in the future. The safe harbors for forward-looking statements
provided by the federal securities laws do not apply to initial public
offerings.


                                       6
<PAGE>

                                 USE OF PROCEEDS


      The net proceeds to Intelli-Check from the sale of the 1,000,000 shares of
      common stock offered by this prospectus are estimated to be $6,163,500, or
$7,153,500 if the underwriters' over-allotment option is exercised in full after
deducting the underwriting discount and estimated offering expenses. We will not
receive any  portion of the  proceeds  from the sale of common  stock by selling
stockholders.


      We expect to use the net proceeds during the twelve months following the
consummation of this offering approximately as follows:


                                                     Approximate    Approximate
                                                       Dollar      Percentage of
Application of Net Proceeds                            Amount      Net Proceeds
- ---------------------------                          -----------   -------------
Purchase of terminals .............................  $2,875,000        46.6%
Repayment of indebtedness .........................   1,225,000        19.9%
Product development ...............................     400,000         6.5%
Sales and marketing ...............................     300,000         4.9%
Working capital and general corporate purposes ....   1,363,500        22.1%
                                                     ----------       -----
  Total ...........................................  $6,163,500       100.0%
                                                     ==========       =====


      Purchase of terminals. We intend to use a portion of the proceeds for the
purchase of ID-Check terminals, which we expect to be delivered by the end of
the second quarter of 2000.

      Repayment of indebtedness. We intend to repay $1,200,000 principal amount
of 27 secured promissory notes bearing interest at the annual rate of 10%, plus
approximately $25,000 of accrued interest, which will be due on the promissory
notes. The promissory notes, the terms of which are identical except for the
principal amounts, mature on the earlier of July 31, 2000 or the closing of this
initial public offering. The proceeds from the sale of these promissory notes
were used for the purchase of ID-Check terminals and for working capital and
general corporate purposes.

      Product development. We intend to continue to enhance the performance and
increase the capability of our ID-Check terminal. We also intend to develop
additional applications for our technology. Costs of product development include
the hiring of additional employees, construction of prototypes and testing.

      Sales and marketing. We expect to hire sales and marketing personnel to
establish a marketing program. We also will be preparing additional marketing
materials and further developing our website.

      Working capital and general corporate purposes. We may use a portion of
the proceeds allocated to working capital and general corporate purposes to pay
trade payables incurred from time to time and the salaries of our employees, if
cash flow from operations is insufficient for these purposes.


      If the underwriters exercise their over-allotment option in full, we will
realize additional net proceeds of $990,000, all of which will be allocated to
working capital and general corporate purposes.


      The foregoing represents our best estimate of the allocation of the net
proceeds of this offering based upon the current status of our business. This
estimate is based on certain assumptions, including the development of our
business in the way we anticipate. If any of our assumptions prove incorrect, we
may find it necessary to reallocate a portion of the proceeds within the
above-described categories or use portions of the proceeds for other purposes.
Our estimates may prove to be inaccurate, new programs or activities may be
undertaken which will require considerable additional expenditures or unforeseen
expenses may occur.

      Based upon our current plans and assumptions relating to our business
plan, we believe the net proceeds of this offering, combined with other
anticipated available cash resources, will be sufficient to meet our cash
requirements for at least twelve months following the closing of this offering.
If our plans change or our assumptions prove to be inaccurate, we may need to
seek additional financing sooner than currently anticipated or curtail our
operations. We cannot assure you that the proceeds of this offering will be
sufficient to fund our proposed growth or that additional financing will be
available if needed.

      Proceeds not immediately required for the purposes described above will be
invested principally in United States government securities, short-term
certificates of deposit, money market funds or other short-term interest bearing
investments.


                                       7
<PAGE>

                                    DILUTION

      The difference between the initial public offering price per share and the
net tangible book value per share of common stock after this offering
constitutes the dilution to investors in this offering. Net tangible book value
is determined by dividing total tangible assets less total liabilities by the
number of outstanding shares of common stock.


      At September 30, 1999, we had a net tangible book value of $42,699, or
$0.01 per share. After giving effect to the sale of 1,000,000 shares of common
stock offered by Intelli-Check by this prospectus, after deducting estimated
underwriting discounts and expenses of this offering, and the application of the
estimated net proceeds, our adjusted net tangible book value as of September 30,
1999 would have been $6,206,199, or $.99 per share. This represents an immediate
increase in net tangible book value of $0.98 per share to existing stockholders
and an immediate dilution of $6.51 (86.8%) per share to new investors.


The following table illustrates the dilution to new investors on a per share
basis:

<TABLE>
<S>                                                                        <C>       <C>

Initial public offering price per share ................................             $7.50
Net tangible book value before offering ................................   0.01
Increase attributable to new investors and pro forma adjustments .......   0.98
                                                                           ----
Adjusted net tangible book value after the offering ....................               .99
                                                                                     -----
Dilution per share to new investors ....................................             $6.51
                                                                                     =====
</TABLE>


      The following table sets forth as of the date of this prospectus, with
respect to our existing stockholders and new investors, a comparison of the
number of shares of common stock we issued, the percentage ownership of those
shares, the total consideration paid, the percentage of total consideration paid
and the average price per share.

<TABLE>
<CAPTION>

                                                        Shares Acquired        Total Consideration      Average
                                                    ---------------------    ----------------------   Price per
                                                      Number      Percent       Amount      Percent      Share
                                                    ----------   --------     -----------  --------    --------
<S>                                                  <C>             <C>     <C>             <C>         <C>
Existing stockholders                                5,271,152       84%     $ 2,871,159     27.7%       $ .54
New investors                                        1,000,000       16%     $ 7,500,000     72.3%       $7.50
                                                     ---------      ---      -----------     ----        -----
Total                                                6,271,152      100%     $10,371,159    100.0%
                                                     =========      ===      ===========    =====
</TABLE>

The above table assumes no exercise of the underwriters' over-allotment option.
If the underwriters exercise the over-allotment option in full, we estimate that
the new investors will have paid $8,625,000 for the 1,150,000 shares of common
stock being offered, representing approximately 75.0% of the total consideration
for 17.9% of the total number of shares of common stock outstanding. In
addition, the above table does not give effect to the shares issuable upon
exercise of outstanding options and warrants.


                                    DIVIDENDS

      We have never declared or paid any dividends to the holders of our common
stock and we do not anticipate paying cash dividends in the foreseeable future.
We currently intend to retain all earnings for use in connection with the
expansion of our business and for general corporate purposes. The future
declaration and payment of dividends, if any, will be within the sole discretion
of our board of directors and will depend upon our profitability, financial
condition, cash requirements, future prospects and other factors deemed relevant
by our board of directors. In addition, the payment of cash dividends on our
common stock in the future could be limited by the terms of financing agreements
that we may enter into or by the terms of any preferred stock that may be
authorized and issued.


                                       8
<PAGE>

                                 CAPITALIZATION

      The following table presents our capitalization as of September 30, 1999
on an actual basis, adjusted to give effect to pro forma information and
adjusted to give effect to our sale of 1,000,000 shares of common stock offered
by us under this prospectus and the anticipated application of the estimated net
proceeds. The share numbers presented in the following table do not include:

      o  150,000 shares of common stock reserved for issuance in this offering
         to cover the over-allotment option;

      o  1,402,000 shares of common stock reserved for issuance upon exercise of
         outstanding stock option plan and non-plan options;

      o  1,681,100 shares of common stock reserved for issuance upon exercise of
         outstanding warrants; and


      o  690,000 shares of common stock reserved for issuance upon exercise of
         options available for future grant under our stock option plans.

<TABLE>
<CAPTION>

                                                                                        September 30, 1999
                                                                                   -----------------------------
                                                                                    Actual          As Adjusted
                                                                                   ----------       ------------
<S>                                                                                <C>              <C>
Short-term debt ................................................................   $1,200,000       $        --
                                                                                   ==========       ===========
Current portion of long-term debt ..............................................   $   17,643       $    17,463
                                                                                   ==========       ===========
Long-term debt .................................................................   $   10,299       $    10,299
                                                                                   ==========       ===========
Stockholders' Equity:
  Preferred Stock Series A, par value $.01 per share, 1,000,000
    authorized, no shares issued and outstanding pro forma or as adjusted          $       --       $        --
  Common Stock, par value $.001 per share, 20,000,000 authorized;
    5,271,152 shares issued and outstanding actual and 6,271,152 shares
    issued and outstanding as adjusted .........................................        5,271             6,271
Additional paid-in capital .....................................................    2,865,888         9,029,388
Accumulated deficit ............................................................   (2,753,272)       (2,753,272)
                                                                                   ----------       -----------
Total Stockholders' Equity .....................................................      117,887         6,282,387
                                                                                   ----------       -----------

Total Capitalization ...........................................................   $  128,186       $ 6,292,686
                                                                                   ==========       ===========
</TABLE>

         The as adjusted short-term debt reflects the expected repayment of
$1,200,000 of secured promissory notes with the proceeds of this offering.

                                       9
<PAGE>

                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS


Overview

      Intelli-Check was formed in 1994 to address a growing need for reliable
age and document verification systems to detect fraudulent driver licenses and
other widely accepted forms of government-issued identification documents. We
have emerged from a development stage company to an operating company and we
recently began commercial production of our product. Our sales to date have been
nominal since we have previously produced only a limited pre-production run of
our product for testing and market acceptance. Since inception, we have incurred
significant losses and negative cash flow, and as of September 30, 1999 we had
an accumulated deficit of approximately $2.75 million. We have not achieved
profitability and expect to continue to incur operating losses. We will continue
to fund operating and capital expenditures from available capital until such
time, if any, as we achieve profitability. In view of the rapidly evolving
nature of our business and our limited operating history, we believe that
period-to-period comparisons of revenues and operating results are not
necessarily meaningful and should not be relied upon as indications of future
performance.

Results of Operations

Comparison of the nine months ended September 30, 1999 to the nine months ended
September 30, 1998.

      Sales decreased 99.6% from $86,354 for the nine months ended September 30,
1998 to $327 recorded for the nine months ended September 30, 1999. Sales for
the period ended September 30, 1998 consisted of sales of our initial
pre-production run of ID-Check terminals while the September 30, 1999 period
only included sales of supplies. In the third quarter of 1998, we withdrew from
the marketplace so that we could devote our resources to expand the capability
of our product by converting our software to operate on programmable terminals.

      Operating expenses, which consist of selling, general and administrative
and research and development expenses, increased 46.8% from $826,799 in the
period ended September 30,1998 to $1,214,146 in the September 30, 1999 period.
Selling expenses, which consist primarily of salaries and related costs for
marketing, increased 45.3% from $118,315 in the period ended September 30, 1998
to $171,908 in the September 30, 1999 period primarily due to the hiring of a
director of national sales. General and administrative expenses, which consist
primarily of salaries and related costs for general corporate functions,
including executive, finance, accounting, facilities and fees for professional
services, increased 56% from $585,887 in the September 30, 1998 period to
$914,239 in the period ended September 30, 1999, primarily as a result of an
increase in salaries because of additional hiring and the fact that our senior
executives did not defer salary after June 1, 1999, an increase in depreciation
and increased professional fees. Research and development expenses, which
consist primarily of salaries and related costs for the development of our
products, remained relatively stable increasing 4.4% from $122,597 in the
September 30, 1998 period to $127,999 in the September 30, 1999 period. We
believe that we require additional significant investments in development and
operating infrastructure, including the hiring of additional sales and marketing
personnel. Therefore, we expect that expenses will continue to increase for the
foreseeable future as we increase expenditures for advertising, brand promotion,
public relations and other marketing activities. We expect that we will incur
additional general and administrative expenses as we continue to hire personnel
and incur incremental costs related to the growth of the business. Research and
development expenses will also increase as we complete and introduce additional
products based upon our patented ID-Check technology.

      Interest expense increased from $23,248 in the period ended September 30,
1998 to $35,584 for the period ended September 30, 1999 as a result of interest
expense on increased deferred compensation and accrued interest on our
promissory notes issued in August and September 1999.

      We have incurred net losses to date, therefore we have paid nominal income
taxes.

      As a result of the factors noted above, our net loss increased from
$785,767 in the period ended September 30, 1998 to $1,249,458 in the September
30, 1999 period.


                                       10

<PAGE>


Comparison of the year ended December 31, 1998 to the year ended December 31,
1997.

      Sales increased 416% from $16,736 for the year ended December 31, 1997 to
$86,354 recorded for the year ended December 31, 1998. Revenues for the year
ended December 31, 1997 were lower because we did not receive the first
pre-production ID-Check terminals until October 1997. Thus, sales did not
commence until the last fiscal quarter for the reasons discussed above.

      Operating expenses decreased 4.6% from $1,579,632 in the year ended
December 31, 1997 to $1,506,615 in the year ended December 31, 1998. This
decrease was attributable to a decline in research and development expenses
partially offset by higher general and administrative costs and selling
expenses. General and administrative expenses increased 6.9% from $992,375 in
the year ended December 31, 1997 to $1,060,537 in the year ended December
31,1998, primarily as a result of increased professional fees. Selling expenses
increased 12.1% from $124,453 in the year ended December 31, 1997 to $139,470 in
the year ended December 31, 1998 as a result of marketing expenses for the
introduction of ID-Check. Research and development expenses decreased 33.7% from
$462,804 in the year ended December 31, 1997 to $306,608 in the year ended
December 31, 1998 primarily due to the completion in 1997 of our software and
hardware development for the pre-production units.

      Interest expense increased from $37,057 in the year ended December 31,
1997 to $61,479 for the year ended December 31, 1998 as a result of interest
expense on increased deferred compensation and borrowings during the year.

      As of December 31, 1998, we had a net operating loss carryforward of
$950,568 for financial reporting purposes. At December 31, 1997, we had no
operating loss carry forward due to our status as a subchapter S corporation
under the Internal Revenue Code for the prior periods. Under subchapter S, all
losses were allocated to our stockholders. We have recorded a valuation reserve
equal to the amount of the carryforward due to the uncertain realization of
these tax benefits.

      Our net loss decreased from a net loss of $1,604,296 in the year ended
December 31, 1997 to $1,503,814 in the year ended December 31, 1998, primarily
as a result of the increase in sales and the decrease in research and
development expenses.


Liquidity and Capital Resources

      Our capital requirements have exceeded our cash flow from operations as we
have been developing our business. At December 31, 1998 we had a working capital
deficit of $924,666. Since inception, we have financed our operations primarily
through private equity and debt financing, issuance of stock for payables and
borrowings from officers. During the year ended December 31, 1997, we received
aggregate net proceeds of $1,917,849 from the private sales of stock and
warrants and issuance of a convertible note payable. During the year ended
December 31, 1998, we received aggregate net proceeds from the private sale of
stock and warrants of $766,000. During the nine months ended September 30, 1999,
we received aggregate net proceeds of $719,200 from the private sale of stock
and warrants. In addition, in August and September 1999, we received aggregate
net proceeds of $1,050,000 from the issuance of promissory notes and warrants.
We used the net proceeds primarily for the purchase of terminals, working
capital and general corporate purposes.

       Cash used in operating activities for the nine months ended September 30,
1999 of $1,253,088 was primarily attributable to the net loss of $1,249,458,
deposits on hardware purchases of $423,905 and increase in other assets of
$148,320 offset by an increase in accounts payable and accrued expenses of
$503,370. Cash used in operating activities for the nine months ended September
30, 1998 of $791,538 was due primarily to net operating losses of $777,867. Cash
used in operating activities for the year ended December 31, 1998 of $1,048,025
resulted primarily from the net loss of $1,503,814 and the increase in inventory
of $122,292, offset by a loss on disposal of assets of $225,783 and increase in
accounts payable and accrued expenses of $262,172. Cash used in operating
activities for the year ended December 31, 1997 of $1,164,986 resulted primarily
from net losses of $1,604,296 offset by an increase in accounts payable and
accrued expenses of $423,651. The increase in accounts payable and accrued
expenses for both periods is attributable to our diminished working capital.
Cash used in investing activities was $85,409 for the nine months ended
September 30, 1999 and $26,006 for the nine months ended September 30, 1998.
Cash used in investing activities was $26,975 for the


                                       11

<PAGE>

year ended December 31, 1998 and $246,264 for the year ended December 31, 1997.
Net cash used in investing activities for these periods consisted primarily of
capital expenditures for computer equipment and furniture and fixtures. Cash
provided by financing activities was $1,941,136 for the nine months ended
September 30, 1999 and $461,343 for the nine months ended September 30, 1998.
Cash provided by financing activities was $752,830 for the year ended December
31, 1998 and $1,866,540 for the year ended December 31, 1997. Cash provided by
financing activities primarily related to the private sales of promissory notes,
common stock, preferred stock and warrants discussed above.

      Because of our limited cash resources, our senior officers deferred the
receipt of their compensation, in whole or in part, prior to June 1, 1999. This
obligation was eliminated through the issuance of stock, warrants and stock
options in the second quarter of 1999. No deferred compensation is currently
outstanding.

      We currently anticipate that our available cash resources combined with
the net proceeds from this offering will be sufficient to meet our anticipated
working capital and capital expenditure requirements for at least twelve months
after the closing of this offering. These requirements are expected to include
the purchase of 5,000 terminals to run our patented software, product
development, sales and marketing, working capital requirements and other general
corporate purposes. We will also repay debt incurred in August and September
1999. We may need to raise additional funds, however, to respond to business
contingencies which may include the need to: fund more rapid expansion; fund
additional marketing expenditures; develop new markets for our ID-Check
technology, enhance our operating infrastructure; respond to competitive
pressures; or acquire complementary businesses or necessary technologies.


Net Operating Loss Carryforwards

      As of December 31, 1998, we had a net operating loss carryforward of
$950,568, which expires beginning in the year 2013. The issuance of equity
securities in the future, together with our recent financings and this offering,
could result in an ownership change and, thus could limit our use of our prior
net operating losses. If we achieve profitable operations, any significant
limitation on the utilization of our net operating losses would have the effect
of increasing our tax liability and reducing net income and available cash
reserves. We are unable to determine the availability of these net operating
losses since this availability is dependent upon profitable operations, which we
have not achieved in prior periods.


Recent Accounting Standards

      In April 1998, the American Institute of Certified Public Accountants
issued Statement of Position 98-1, "Accounting for the Costs of Computer
Software Developed or Obtained for Internal Use" ("SOP 98-1"), which provides
guidance for determining whether computer software is internal-use software and
on accounting for the proceeds of computer software originally developed or
obtained for internal use and then subsequently sold to the public. It also
provides guidance on capitalization of the costs incurred for computer software
developed or obtained for internal use. SOP 98-1 is effective for fiscal years
beginning after December 31, 1998. We do not expect the adoption of SOP 98-1 to
have a material effect on our financial statements.

      In June 1998,  the Financial  Accounting  Standards  Board issued SFAS No.
133,  "Accounting for Derivative  Instruments and Hedging  Activities." SFAS No.
133 establishes  accounting and reporting standards for derivative  instruments,
including derivative  instruments  embedded in other contracts,  and for hedging
activities.  SFAS No. 133 was originally to be effective for all fiscal quarters
of fiscal years beginning after June 15, 1999. In July 1999,  however,  the FASB
issued  SFAS  No.  137,  "Accounting  for  Derivative  Instruments  and  Hedging
Activities -- Deferral of the Effective  Date of FASB  Statement No. 133," which
amends SFAS No. 133 to be effective for all fiscal  quarters of all fiscal years
beginning  after June 15, 2000.  We currently do not engage or plan to engage in
derivative instruments or hedging activities.


Year 2000 Issues

      Many currently installed computer systems and software products are coded
to accept or recognize only two digit entries in the date code field. These
systems and software products may recognize a date using "00" as the year 1900
rather than the year 2000. As a result, computer systems and/or software used by
many companies


                                       12
<PAGE>


and governmental agencies may need to be upgraded to comply with
such Year 2000 requirements or risk system failure or miscalculations causing
disruptions of normal business activities.

      State of Readiness. We have made a preliminary assessment of the Year 2000
readiness of our information technology systems, including our ID-Check
software, and our non-information technology systems. Our plan consists of:

      o  quality assurance testing of our internally developed proprietary
         software;

      o  contacting third-party vendors and licensors of material hardware,
         software and services;

      o  contacting vendors of material non-information technology systems;

      o  assessment of repair or replacement requirements;

      o  repair or replacement; and

      o  implementation.


      We have substantially completed a review and assessment of all proprietary
and third party hardware and software and believe that our hardware and software
are substantially Year 2000 compliant. We have made inquiries of a number of our
vendors requesting assurances of their compliance. These third parties,
including our supplier of terminals for the ID-Check software, have generally
advised us that their review of their operating systems indicate that their
operating systems are Year 2000 compliant or will be Year 2000 compliant in a
timely manner.

      Costs. To date, we have not incurred any material costs in identifying or
evaluating Year 2000 compliance issues. Most of our expenses have been and will
continue to be related to the operating costs associated with evaluating Year
2000 compliance matters generally.

      Risks. We are not currently aware of any Year 2000 compliance problems
that would have a material adverse effect on our business, results of operations
and financial condition. However, we may discover Year 2000 compliance problems
that will require substantial software revisions or replacement of hardware. Our
failure to fix or replace software or hardware on a timely basis could result in
lost revenues, increased operating costs and the loss of customers and other
business interruptions, any of which could have a material adverse effect on our
business, results of operations and financial condition. Moreover, the failure
to adequately address Year 2000 compliance issues could result in claims of
mismanagement, misrepresentation or breach of contract and related litigation,
which could be costly and time-consuming to defend.

      In addition, we cannot assure you that third-party software or hardware
incorporated into our material systems or other systems upon which we rely will
not need to be revised or replaced, which could be time consuming and expensive.
In addition, we cannot assure you that governmental agencies, utility companies,
third-party service providers and others outside of our control will be Year
2000 compliant. The failure by such entities to be Year 2000 compliant could
result in a systemic failure beyond our control. Any of these occurrences could
have a material adverse effect on our business, financial condition and results
of operations. At this time, we do not possess the information necessary to
estimate the potential costs of revisions to or the replacement of software or
hardware that are determined not to be Year 2000 compliant. Although we do not
anticipate that such expenses will be material, such expenses, if higher than
anticipated, could have a material adverse effect on our business, financial
condition and results of operations.

      Contingency Plan. As discussed above, we are engaged in an ongoing Year
2000 assessment and have not yet developed any contingency plans. The results of
our Year 2000 simulation testing and the responses received from third-party
vendors and service providers will be taken into account in determining the
nature and extent of any contingency plans.



                                       13
<PAGE>


                                    BUSINESS

Introduction

      Intelli-Check was formed in 1994 to develop, manufacture and market an
advanced document verification system to enable a retailer to:

      o  determine the customer's age and the validity of the ID identity to
         detect and prevent the use of fraudulent identification for the
         purchase of alcohol, tobacco and other age-restricted products;

      o  reduce the risk to the retailer of substantial monetary fines, criminal
         penalties and license revocation for the sale of age-restricted
         products to minors; and

      o reduce check cashing, credit card and other types of fraud.


      In an effort to combat these problems, the federal government and many
states and Canadian provinces have enacted laws requiring businesses that sell
age-restricted products to verify the ID of potential customers to determine if
they are of legal age. These laws impose stringent penalties. In addition, many
states and local governments are setting up undercover "sting" operations to
detect violations.

      The product we have designed and developed is based on our patented
ID-Check technology. ID-Check provides businesses with a reliable, simple and
cost-effective way to verify age and reduce the risk of severe penalties for
non-compliance with these laws. We have not manufactured or sold a substantial
number of ID-Check terminals to date. In 1998, we launched a limited
pre-production pilot program by installing an earlier version of our ID-Check
terminal in 68 locations throughout the United States and Canada. Of the 68
installations, 32 are convenience stores, 24 are bars and 12 are in a variety of
other retail establishments. Based on the positive reaction of our customers, we
have begun commercial production of an enhanced ID-Check terminal for more
widespread distribution.


      Driver license

      The driver license is the most widely used form of government issued photo
identification. We believe the driver license has become a de facto
identification card. In addition to its primary function, the driver license is
used in social services, gun control, check cashing and other applications.


      Non-driver identification card

      Although many people do not have a driver license, jurisdictions that use
AAMVA compliant driver licenses offer other identification cards that contain
encoded information. These identification cards, as well as military ID's and
immigration "Green" cards, are fundamentally identical to driver licenses.
Because driver licenses are the most widely used form of legally acceptable
governmental identification we refer to all of these types of documents as
"driver licenses" in this prospectus. Our ID-Check software is equally capable
of performing its function with all of these types of government identification.


      AAMVA guidelines

      In response to the ease with which driver licenses and non-driver
identification cards can be altered, tampered with or fraudulently obtained, an
increasing number of states and Canadian provinces have adopted the guidelines
established by the American Association of Motor Vehicle Administrators (AAMVA)
and the American National Standards Institute (ANSI). AAMVA is a U.S. based
international organization that establishes guidelines for motor vehicle
administrators in NAFTA countries. Currently, 32 states and 6 Canadian provinces
conform with AAMVA guidelines that suggest driver licenses and non-driver
identification cards contain "encoded" information on magnetic stripes or bar
codes, which cannot be accurately read without the necessary decoding equipment
and technology. Based on our discussions with government officials,
manufacturers of driver licenses and members of various other driver license
committees, we expect that additional U.S. states and Canadian provinces will
implement plans to issue driver licenses that contain information in
electronically readable format complying with AAMVA guidelines.


                                       14
<PAGE>



      We have entered into a Memorandum of Understanding, effective November 15,
1999, with AAMVAnet, Inc., a subsidiary of AAMVA for Intelli-Check to provide
testing services to AAMVAnet, for which we will receive reimbursement of our
expenses.



Underage Use of Alcohol and Tobacco Products and the Need for Age Verification


      Overview

      Underage access to age-restricted products, like alcohol and tobacco,
remains a major societal problem, as the following statistics indicate:

      o  according to Connecticut Clearinghouse, approximately 10.6 million or
         51.2% of high school students in the United States drink alcoholic
         beverages at least once weekly, with 86% purchasing the alcohol
         themselves;

      o  the Office of Drug Control Policy reported that approximately 9.5
         million drinkers of alcoholic beverages in 1996 were between the ages
         of 12 and 20, according to the U.S. Department of Justice Office of
         Juvenile Justice and Delinquency Prevention;

      o  The Insurance Institute for Highway Safety has said that, in 1997, 26%
         of 16-20 year olds fatally injured in motor vehicle crashes had high
         blood alcohol concentrations;

      o  according to the Journal of Adolescent Health, approximately 3,000
         minors begin smoking regularly every day;

      o  join together Online's Fact Finder reports that underage youths can
         purchase cigarettes successfully 70%-80% of the time over the counter
         and 90%-100% of the time through vending machines; and

      o  Join Together also reports that each year merchants illegally sell
         minors 947 million packs of cigarettes and 26 million containers of
         chewing tobacco worth $1.26 billion.


      To combat these problems, most states have enacted laws which provide for
substantial penalties for businesses that sell tobacco and alcohol to minors.


      Regulation of retailers of tobacco products

      New federal regulations have been enacted that place a greater burden on
retailers to prevent the sale of tobacco products to minors. Clerks are required
to check the photo ID of anyone who is trying to purchase tobacco products and
appears to be under the age of 27.

      According to the Coalition for Tobacco Retailing, penalties for the sale
of tobacco products to minors include:

      o  state fines of up to $6,000 per violation and/or 1 year in jail;

      o  federal fines of up to $10,000 for the fifth violation and
         discretionary penalties for any subsequent violations;

      o  criminal charges against the selling establishment and/or its
         employees; and

      o revocation or suspension of the retailer's tobacco license.


      Regulation of retailers of alcoholic beverages

      The retailer of alcoholic products who sells to an underage person will
face fines, suspension of its license and the potential outright revocation of
its license to sell alcoholic beverages.

      According to "Youth and Alcohol, Selected Reports to the Surgeon General,"
published by the U.S. Department of Education, state imposed penalties for the
sale of alcohol to minors include:

      o  fines of up to $10,000 and/or 5 years in jail;

      o  administrative penalties levied by alcoholic beverage control agencies
         ranging from fines of up to $5,000 and a six-month license suspension;


                                       15
<PAGE>


      o  criminal charges against owner and/or employees; and

      o "dram shop" laws which permit civil lawsuits to be brought against
businesses.


      Some statistics concerning enforcement activity

      o  according to the Washington State Liquor Control Board, in June 1999,
         the State of Washington visited 273 locations to detect tobacco sale
         violations. 15.38% of the businesses visited were found to have sold
         tobacco products to underage persons

      o  during 1997 - 1998, the State of California Department of Alcohol
         Beverage Control conducted 291 "Minor Decoy Operations", each
         consisting of multiple on-site checks. Of the 6,568 visits to Alcoholic
         Beverage Control licensed businesses, 20.63% or 1,355 were found to
         have sold alcoholic beverages to the decoy

      o  the State of California Department of Alcohol Beverage Control has said
         that most of the accusations filed for violations against alcohol
         licensees in California are for sales of alcoholic beverages to minors

      o  as reported in the Orlando Sentinel, in 1998, the Florida State
         Department of Highway Safety reviewed 5,973 fraud cases in Florida and
         invalidated 19% or 1,143 of the driver licenses inspected.


      As a result of these and other law enforcement efforts and regulatory
penalties, we believe retailers that sell alcohol and tobacco, such as liquor
stores, bars and convenience stores, are facing increasing pressure to
accurately verify the age of their customers.


      The use of false identification

      Fraudulent driver licenses can be easily produced using readily available,
advanced color copiers and other equipment. These false documents are easily
obtainable from a number of locations, such as college campuses, and over the
Internet. Starting with only a fraudulent driver license, an individual, in
addition to buying alcohol and tobacco products while underage, may be able to
create multiple identities, commit fraud, evade law enforcement and engage in
other criminal activities, such as:

      o  forging checks supported by false identification;

      o  providing additional identification for the use of stolen credit cards;

      o  creating a false identity in order to evade law enforcement; and

      o unlawfully obtaining welfare or other government benefits.


      Given the ease with which identification can be falsified, simply looking
at a driver license may not be sufficient to verify age or identity and
determine whether or not it is fraudulent. Rather, what is needed is a system
which can accurately read the electronically stored information. We are not
aware of any other patented software application technology that provides an
analysis of all the data contained on these documents for the purpose of age and
document verification by reading and comparing the information encoded in all of
the tracks of the magnetic stripe or bar code on the driver license.

      ID-Check and Benefits

      We believe the ID-Check solution is the most advanced, reliable and
effective technology, providing retailers with an easy to use, reliable, and
cost-effective method of age and identity verification. We have received
encoding and encryption formats from each jurisdiction that conforms to AAMVA
guidelines, including military and immigration authorities in the U.S. and
Canada. This information, combined with our patented technology, enables the
ID-Check software to read, decode and process all of the information
electronically stored on driver licenses. As jurisdictions and AAMVA change
their documents and guidelines, we believe our software, together with our
programmable terminal, can be adapted to these changes.

      ID-Check terminals do not require a connection to a central data base to
operate. Our terminals have the ability to operate add-on peripherals such as
printers, bar code scanners, modems and other devices, which


                                       16
<PAGE>


would enhance the functionality of the terminals and potentially create the
opportunity for sales of other software products by us.

      The ID-Check process is quick, simple and easy to use. After matching the
photograph on the driver license to the person presenting the document for
identification, the clerk or employee simply swipes the driver license through
the ID-Check terminal if the card has a magnetic stripe or scans it if it has a
bar code. The terminal quickly determines if the document:

      o  has been altered;

      o  has expired; and

      o  has a date of birth equal to or greater than the legal age to purchase
         either or both alcohol and tobacco products in the retailer's location.

Then, the terminal will automatically:

      o  print a record of the transaction including the results on a roll of
         paper similar to that used in cash registers, if an optional printer
         has been installed;

      o  save information to the terminal's own memory to be downloaded at a
         later time;

      o  respond to the user by illuminating an appropriate, easily recognizable
         symbol reflecting the results for both alcohol and tobacco, or in words
         on the terminal's screen; and

      o  send the results to a PC for permanent storage and/or analysis in
         conjunction with our related software products.

     Other currently available age verification products

      Unless a device can read, decode and analyze all of the information
electronically stored on a driver license, the user may not obtain accurate and
reliable confirmation that a driver license is valid and has not been altered or
tampered with. We are aware of several companies, including Secure ID LLC and
The IdentiScan Company, LLC, that are currently offering products that
electronically read and calculate age from a driver license. We have tested and
compared some of these products to ID-Check and believe that our product is
superior in quality and functionality. These other products are based on credit
card terminal equipment. Most cannot process bar codes. This is a significant
disadvantage because nearly 22% of the currently issued driver licenses contain
bar codes. In addition, most of these other products cannot connect to a PC or
use a printer. Furthermore, these products cannot distinguish between a credit
card and a driver license, thus limiting their effectiveness. We also believe
that some of these products may infringe on our patent. In determining whether
and when it is appropriate to commence litigation to protect our intellectual
property rights, we intend to carefully examine each instance of potential
infringement on a case-by-case basis and to weigh the potential damage caused by
any infringement against the demands a patent infringement litigation would
place on our financial and management resources.

      There are also products being marketed which are essentially electronic
calendars designed to assist the retailer in calculating the age of the person
presenting a driver license. These devices, however, cannot determine whether a
driver license is valid or has been altered.

      A small number of laminate verifiers are currently used to determine the
validity of the laminate on a driver license. However, laminate verifiers are
fragile, not reliable and can only be used in one state, New York, which is
currently considering replacing the laminate in its next generation of licenses.

      Our Marketing and Distribution Strategy

      Our objective is to become the leading developer and distributor of age
and document verification products. To date, we have engaged in limited
marketing efforts primarily through management's participation in trade shows.
We are developing a comprehensive marketing plan to build customer awareness and
develop brand recognition in target markets. Initially, we intend to promote the
advantages and ease of use of the ID-Check terminal through:

      o trade publications;

      o trade shows;


                                       17
<PAGE>

      o conventions and seminars;

      o direct mail; and

      o our website.

      We also intend to seek endorsements from leading companies in the alcohol
and tobacco industries, public interest organizations and trade associations,
which we believe have an interest in discouraging illegal purchases of
age-restricted products.

      As we gain market acceptance of the ID-Check terminal, we intend to
commence marketing efforts for subsequent upgrades and related software
applications.


      Distribution strategy

      In April 1999, we hired a director of national sales and in October 1999
we hired a vice president-sales. We intend to use a portion of the proceeds from
this offering to prepare additional marketing materials, hire additional sales
and marketing support staff and continue to develop our marketing strategy.


      Our initial target markets

      Our initial target markets for the ID-Check terminal will be retail
establishments. We intend to initially focus our marketing efforts towards:

      o  convenience stores;

      o  bars and night clubs;

      o  restaurants; and

      o  retail beer and liquor stores.


      Independent sales organizations

      Management estimates there are thousands of businesses referred to as
independent sales organizations (ISO's), which specialize in marketing equipment
having a purchase price of under $5,000. We have entered into an agreement with
Northern Leasing Systems, a leading privately-held equipment lease finance
company specializing in this type of equipment, to be our exclusive lease
finance company and the exclusive marketer of our ID-Check product to ISO's. The
agreement automatically renews annually, subject to Northern Leasing having
purchased, either directly or through ISO's, 2,500 terminals by the end of the
first year, 12,000 terminals by the end of the second year and 15,000 terminals
each year thereafter. We believe that the ID-Check terminal is a complementary
product that can be sold or leased to many of the ISO's existing customers.


      Distributors of alcohol and tobacco products

      Many distributors of alcohol and tobacco products sell related products
and supplies to retail merchants. We believe the ID-Check terminal is a
complementary product and offers a marketing opportunity to these distributors.
We are currently in discussions with a distributor of alcohol and tobacco
products, with a view to entering into a distribution agreement under which the
distributor would receive the exclusive right to distribute the ID-Check
terminal within a specified territory to retail merchants of alcohol products.
This right would expire if the distributor fails to meet specified sales goals.
We do not know if we will be successful in entering into this agreement.
Furthermore, we cannot assure you that any such arrangement would be profitable.

      Revenue Sources

      We initially intend to generate revenues from the sale or lease of
ID-Check terminals and sale of software upgrade cards.

      ID-Check terminals

      Our patented ID-Check software will initially be installed in a
self-contained terminal similar to those commonly used as credit card terminals,
which we intend to market to retailers for approximately $2,000 each.


                                       18
<PAGE>


      Upgrade cards

      Our software will require periodic updates as states that did not
previously conform to AAMVA guidelines begin to store electronically readable
information on their driver licenses and as states adjust or modify the format
of their electronically stored information. We intend to sell upgrade cards
which can be used to instantly upgrade the terminal by simply swiping the
upgrade card through the ID-Check terminal. Because each terminal has a unique
serial number, the upgrade card will only work with that terminal, making
unauthorized copying of these cards valueless. We also intend to develop a
secure way of delivering upgrades through the Internet.

      The ID-Check guide to US and Canadian ID's

      The United States and Canada are moving toward uniformity in their driver
licenses and identification cards. However, some states and provinces have not
yet adopted AAMVA and/or ANSI guidelines. Because of our familiarity with these
government documents, we intend to offer a printed manual to provide financial
institutions, government agencies and retail stores with a method of verifying
document authenticity when documents are presented which do not have information
electronically stored on either a magnetic stripe or bar code. We intend to
market this product directly through our sales personnel.


Additional Target Customers

      In addition to retailers of alcohol and tobacco products, others that
could benefit by using the ID-Check terminal include:

      o  car rental agencies;

      o  hotels and motels;

      o  stadiums and arenas;

      o  firearm merchants;

      o  gaming establishments;

      o  movie theaters;

      o  law enforcement agencies; and

      o  vending machine manufacturers.


Products in Development

      We have begun developing the following products:

      MAVE. In April 1998, we built two prototypes of a hand-held portable
version of our ID-Check terminal specifically designed for law enforcement. We
have trademarked this product as MAVE for Mobile Age Verification and
Enforcement. One prototype was loaned to the State of Florida's Division of
Alcoholic Beverage & Tobacco Control's Tobacco Pilot Program for Enforcement. In
March 1999, we shipped three units to enable the Division to begin a pilot
program to fully evaluate MAVE. After the completion of this offering, we intend
to begin limited commercial production of MAVE.

      P-Link. P-Link is a software application designed to replicate the
features of ID-Check using existing hardware (or with minimal additional
hardware components) included in Point-Of-Sale (POS) terminals for multi-lane
retailers such as grocery and mass-retail stores. The POS terminal would halt
the purchase of age-restricted products until a driver license is verified by
the P-Link software application. Once the age-verification process has been
completed, the terminal would block age-restricted products from being totaled
into the sale if the unit shows that the customer is underage. This product is
intended to be marketed directly to manufacturers and integrators of POS
terminals to expand their product capabilities.

      C-Link and M-Link. We have developed and distributed two pre-production
Microsoft Windows 95/98/NT compatible software products that work in conjunction
with our ID-Check terminal. These products are called C-Link and M-Link. C-Link
collects the information read by the ID-Check terminal and saves it to a



                                       19
<PAGE>


PC hard drive for permanent storage. Once saved, the information can be
searched, analyzed and used to easily generate demographics, statistics and
mailing lists to existing customers. M-Link expands C-Link's abilities to
maintain memberships and customer loyalty programs to encourage repeat
customers. M-Link is intended to be sold separately as a service pack, which
extends the functionality of C-Link's software.


Possible Future Uses for our Technology

      We believe that our patented ID-Check technology has applications in a
variety of other areas. Some examples of potential users for ID-Check technology
include:

      o  airlines, since FAA regulations require passengers over 18 years old to
         produce a valid driver license or other form of legally acceptable
         picture identification in order to board any airliner domestically;

      o  credit card terminal manufacturers, which could use our technology to
         verify that the credit card holder has presented a valid driver license
         prior to processing the purchase; and

      o  financial services companies, which could use our technology to verify
         the validity of a driver license presented in connection with check
         cashing, opening a new account or a mortgage application.

      Although we anticipate that this effort will require an indeterminate
amount of time and resources, we intend to use a portion of the $400,000 of the
proceeds of this offering allocated for product development to begin developing
these possible future uses for our technology. We do not currently have more
specific plans to develop any of them.

      In addition, we may in the future seek to license our technology to
manufacturers of scanning devices or others to enhance the functionality of
their products. We do not currently have any specific plans to enter into these
types of licenses.


Manufacturing

      We have engaged a subsidiary of Welch Allyn, Inc., a leading
privately-held manufacturer of medical equipment and bar code readers and
scanners, to provide a programmable terminal to operate our patented ID-Check
software. We have placed an order for 525 ID-Check terminals, which are expected
to be delivered during November 1999. These terminals will have most, but not
all, of the features of an upgraded version of our initial product. Most of the
net proceeds of the private placement in August and September 1999 were used to
purchase approximately 1,000 units of an upgraded version of our ID-Check
terminal. We expect delivery of these terminals to begin in the first quarter of
2000, which will enable us to commence more widespread marketing.


Technical Support and Maintenance

      The ID-Check hardware terminals are certified by Underwriters Laboratory
(UL) and its European equivalent (CE) for retail use and are virtually
maintenance-free other than occasional surface cleaning.

      Technical support will be provided by us to our customers through:

      o  our website (E-mail) on the Internet;

      o  tips and hints on our website; and

      o  a toll-free number.

      Technical  support will be provided  during  normal  business  hours and a
voice mailbox will be capable of
taking messages during non-business hours.

Competition

      We expect that competition may become intense in the markets addressed by
us. We may compete with a large number of companies, many of which may be
substantially larger and have significantly greater capital and management
resources than we do. We believe that we may have some advantage over potential
competitors


                                       20
<PAGE>


because we have been issued one patent and five copyrights on our software and
because of the substantial time that we have spent in developing our software
and hardware and in developing a substantial database of information relating to
the encoded information of each jurisdiction. However, we cannot assure you that
we will be able to compete successfully.

Intellectual Property

      In January 1999, we were issued a patent on our ID-Check software
technology. We have also been granted five copyrights in the United States,
which are effective in Canada and 17 other major industrial countries. The
patent covers a specific process relating to ID-Check, including age
verification from a driver license. In addition, the copyright protection covers
software source codes and supporting graphics relating to the operation of
ID-Check and other software products. We have also received several trademarks
relating to our company, its product names, and logos. We cannot assure you as
to the degree of protection which the patent may afford, or that our patent
would be upheld if challenged or that other companies will not develop similar
or superior methods or products outside the protection of the patent issued to
us.

      We also rely on proprietary knowledge and employ various methods,
including confidentiality agreements, to protect our software codes, concepts,
ideas and documentation of our proprietary technology. However, these methods
may not afford complete protection and we cannot assure you that others will not
independently develop similar knowledge.

      Under an agreement with Mr. Messina, we will pay royalties equal to 0.005%
of gross sales from $2,000,000 to $52,000,000 and 0.0025% of gross sales in
excess of $52,000,000.

      The IdentiScan Company, LLC offers a product that electronically reads and
calculates age from a driver license. Representatives of IdentiScan had met with
us on several occasions in the past, at their suggestion, to discuss a merger
between the two companies. We declined to proceed with those discussions. We
have informed IdentiScan that we believe its product may infringe on our patent.
In response, in August 1999, IdentiScan filed a complaint against us which seeks
to have the IdentiScan product declared non-infringing on our patent and seeks
to have our patent declared invalid. The complaint does not seek monetary
damages. We believe that our patent, to which we hold clear title, is valid and
fully enforceable. We intend to vigorously defend it. We also believe
IdentiScan's claim of non-infringement is without merit. In October 1999, we
made a motion to dismiss IdentiScan's claim. This motion is currently pending.
However, if our patent were to be declared invalid or if our patent were to be
otherwise limited, we believe it would have an adverse effect on our business
and future success because other companies, including IdentiScan, might be able
to use some or all of the technology covered by our patent to develop and market
products which will directly compete with ID-Check.

      We are not aware of any infringement by our products or technology on the
proprietary rights of others. Nevertheless, infringement or invalidity claims
may be asserted against us and we could incur significant expense in defending
them. If any claims or actions are asserted against us, we may be required to
modify our products or seek licenses for these intellectual property rights. We
may not be able to modify our products or obtain licenses on commercially
reasonable terms, in a timely manner or at all. Our failure to do so could
adversely affect our business.


      The names "ID-Check", "P-Link", "C-Link", "M-Link", "MAVE", "AIR-Check",
and "CREDIT-Check" are trademarks of Intelli-Check. Each trademark, trade name
or service mark of any other company appearing in this prospectus belongs to its
holder.



Employees


      As of November 11, 1999, we had thirteen full-time employees, including
three who are engaged in executive management, three programmers, four in sales
and marketing and three administrative staff. We believe our relations with our
employees are generally good and we have no collective bargaining agreements
with any labor unions.



                                       21
<PAGE>


Facilities

      Our executive offices are located in Huntington, New York, where we occupy
approximately 4,200 square feet of leased space pursuant to a lease expiring on
October 31, 2000. Minimum payments under the lease are $78,420 per year for 1999
and with a maximum increase of no greater than 4% for each remaining year of the
lease.


Legal Proceedings

      We are in dispute with our landlord, Huntington Atrium, which brought a
lawsuit against us in 1998 in the District Court, County of Suffolk, State of
New York, relating to our original occupancy date and to determine the party
responsible for improvements to the space. The landlord's claim is for
approximately $177,000 and our counterclaim is for approximately $50,000. While
we believe that we have meritorious defenses to the landlord's claim, an adverse
decision would not have a material adverse effect on our company.

      As discussed above, in August 1999, IdentiScan filed a complaint against
us in the United States District Court for the District of Connecticut which
seeks to have the IdentiScan product declared non-infringing on our patent and
seeks to have our patent declared invalid. The complaint does not seek monetary
damages. We believe that our patent, to which we hold clear title, is valid and
fully enforceable. We intend to vigorously defend it. We also believe
IdentiScan's claim of non-infringement is without merit. In October 1999, we
made a motion to dismiss IdentiScan's claim. This motion is currently pending.

      Other than as set forth above, we are not currently involved in any legal
or regulatory proceeding, or arbitration, the outcome of which is expected to
have a material adverse effect on our business.


                                       22
<PAGE>


                                   MANAGEMENT

Executive Officers and Directors

      The following table sets forth the ages of and positions and offices
presently held by each director and executive officer of Intelli-Check:

<TABLE>
<CAPTION>


     Name                         Age              Position
     -----                        ---               -------
<S>                               <C>
 Frank Mandelbaum................. 65  Chairman, Chief Executive Officer and Director
 Kevin Messina.................... 33  President, Chief Technology Officer and Director
 Edwin Winiarz.................... 41  Executive Vice President, Treasurer and  Chief Financial
                                        Officer and Director
 W. Robert Holloway............... 59  Vice President-Sales
 Paul Cohen....................... 59  Director
 Anthony Broderick................ 56  Director
 Evelyn Berezin................... 74  Director
 Charles McQuinn.................. 59  Director
</TABLE>



      Frank Mandelbaum has served as our Chairman of the Board, Chief Executive
Officer since July 1, 1996. He also served as Chief Financial Officer until
September 1999. From January 1995 through May 1997, Mr. Mandelbaum served as a
consultant providing strategic and financial advice to Pharmerica, Inc.
(formerly Capstone Pharmacy Services, Inc.), a publicly held company. Prior to
January 1995, Mr. Mandelbaum was Chairman of the Board, Chief Executive Officer
and Chief Financial Officer of Pharmerica, Inc. From July 1994 through December
1995, Mr. Mandelbaum served as Director and Chairman of the Audit and
Compensation Committees of Medical Technology Systems, Inc., also a publicly
held company. From November 1991 through January 1995, Mr. Mandelbaum served as
Director of the Council of Nursing Home Suppliers, a Washington, D.C. based
lobbying organization. From 1974 to date, Mr. Mandelbaum has been Chairman of
the Board and President of J.R.D. Sales, Inc., a privately held financial
consulting company. As required by his employment agreement, Mr. Mandelbaum
devotes substantially all his business time and attention to our business.

      Kevin Messina, a co-founder of Intelli-Check, was elected President and
appointed as Chief Technology Officer in June 1998. From our company's inception
in October 1994 to June 1998, Mr. Messina served as our Executive Vice
President, Chief Information Officer and Secretary. Prior to October 1994, Mr.
Messina was the founder and President of K.M. Software, which served the banking
and commodities industries. During 1998 and 1999, Mr. Messina was selected to
serve on various industry councils for AAMVA and various committees of ANSI and
the International Standards Organization (ISO). In August 1998, Mr. Messina was
elected to the US delegation representing ANSI, the National Committee for
Information and Technical Standards, the Information Technology Industry
Council, the International Electrotechnical Commission and various other
national bodies that are members of ISO. In November 1998, Mr. Messina was
elected chairperson of the committee which was in charge of recommending
encryption and bar code formats. Since then, ANSI has adopted the recommendation
as the standard for U.S. and Canadian driver licenses and ID cards for the
five-year period ending in 2005.

      Edwin Winiarz was elected a director in August 1999 and became Executive
Vice President, Treasurer and Chief Financial Officer on September 7, 1999. From
July 1994 until August 1999, Mr. Winiarz was Treasurer and Chief Financial
Officer of Triangle Service Inc., a privately held national service company.
From November 1990 through July 1994, Mr. Winiarz served as Vice President
Finance/Controller of Pharmerica, Inc. (formerly Capstone Pharmacy Services,
Inc.). From March 1986 until November 1990, Mr. Winiarz was a manager with the
accounting firm of Laventhal & Horwath. Mr. Winiarz is a certified public
accountant and holds an MBA in management information systems from Pace
University.

      W. Robert Holloway became Vice President-Sales in October 1999. From April
1999 to October 1999, Mr. Holloway was Director of Sales for The IdentiScan
Company LLC. In February and March 1999, Mr. Holloway worked as an independent
consultant. From August 1996 to January 1999, Mr. Holloway was Global Sales
Manager for Welch Allyn, Inc. From October 1994 to July 1996, Mr. Holloway was
Vice President and Sales Manager of Bowne & Company of New York. Mr. Holloway
holds an AB in economics from Columbia University and an MBA in finance from
Boston University.


                                       23
<PAGE>


      Paul Cohen has served as a director of Intelli-Check since November 1996.
From December 1990 to present, Mr. Cohen has been the director of
pharmaceuticals for Allou Health and Beauty Care, Inc, a public company. Paul
Cohen is the father of Todd Cohen, our former President.

      Anthony Broderick has served as a director of Intelli-Check since November
1996. Mr. Broderick is an independent aviation safety consultant whose clients
include international airlines, aerospace firms, a major aircraft manufacturer,
and governments. From June 1976 to June 1996, when he retired, Mr. Broderick was
Associate Administrator for Regulation and Certification in the Federal Aviation
Administration. Prior to June 1976, Mr. Broderick was employed with the U.S.
Department of Transportation from February 1971. Mr. Broderick has been the
recipient of numerous awards recognizing his distinguished service and
leadership in the field of airline safety.

      Evelyn Berezin was elected a director in August 1999. She has been, since
October 1987, an independent management consultant to technology based
companies. From July 1980 to September 1987, Ms. Berezin was President of
Greenhouse Management Company, a venture capital fund dedicated to investment in
early-phase high-technology companies. Ms. Berezin holds an AB in Physics from
New York University and has held an Atomic Energy Commission Fellowship. Ms.
Berezin is currently a member of the Board of Directors of Bionova Corp., a
publicly held biotechnology company. In addition, she has served on the boards
of a number of other public companies including Cigna Corp., Datapoint Corp.,
Koppers Company, Inc. and Genetic Systems Inc., as well as more than fourteen
private technology-based companies.

      Charles McQuinn was elected a director in August 1999. He has been, since
1997, an independent product development marketing consultant to Internet based
companies. In this position, he has been responsible for the development of four
fixed income electronic trading systems for Zions Bank, which target the markets
of dealers, institutions, retail and Bloomberg News Service. Mr. McQuinn has
also served as President of The McQuinn Group, Inc., a system integration and
institutional marketing company, from November 1998 to the present. From 1995 to
1997, Mr. McQuinn was President of DTN West, a fixed income price quote company
with products for banks and governments. From 1990 to 1995, Mr. McQuinn was
President of Bonneville Market Information, an equities price quote company with
products for traders and brokers. From 1985 to 1990, Mr. McQuinn was President
of Bonneville Telecommunications Company, a satellite video and data company.
Prior to 1985, he was with Burroughs Corporation in various product
development/marketing/management positions. Mr. McQuinn holds a BS in marketing
from Ball State University and an MBA in management from Central Michigan
University.

      Directors are elected at each annual meeting of stockholders and hold
office until the next annual meeting of stockholders and the election and
qualification of their successors. Executive officers are elected by and serve
at the discretion of the board of directors.

      We have agreed, for a period of 36 months from the date of this
prospectus, if so requested by the underwriters, to select a designee of the
underwriters as a non-voting adviser to our board of directors. The underwriters
have not yet exercised their right to designate such a person.


Board Committees

      The board of directors has established a compensation committee which is
comprised of Mr. Broderick, chairman, Mr. Mandelbaum and Mr. Cohen. The
compensation committee reviews and determines the compensation for all officers
and directors of our company and reviews general policy matters relating to the
compensation and benefits of all employees. The compensation committee also
administers the stock option plans.

      The board of directors has established an audit committee which is
comprised of Ms. Berezin, chairman, Mr. McQuinn and Mr. Cohen. The audit
committee recommends to the board of directors the annual engagement of a firm
of independent accountants and reviews with the independent accountants the
scope and results of audits, our internal accounting controls and audit
practices and professional services rendered to us by our independent
accountants.


                                       24
<PAGE>


      The board of directors has established a corporate governance committee,
which is comprised of Mr. McQuinn, chairman, Ms. Berezin and Mr. Broderick. The
corporate governance committee reviews our internal policies and procedures.


Director Compensation

      Non-employee directors receive a fee of $500 for attending board meetings
and $250 for attendance at such meetings telephonically. They also receive a fee
of $300 for each committee meeting held on a date other than that of a board
meeting and are reimbursed for expenses incurred in connection with the
performance of their respective duties as directors. In August 1999, each
non-employee director, Messrs. Paul Cohen, Broderick and McQuinn and Ms.
Berezin, received a grant of a non-qualified stock option to purchase an
aggregate of 45,000 shares of our common stock upon their election as a director
at an exercise price of $3.00 per share. Of these options, 15,000 are
immediately exercisable and an additional 15,000 will be exercisable on the
succeeding two anniversaries of the date of grant, provided the director is
re-elected. Options granted to non-employee directors are exercisable only
during the non-employee director's term and automatically expire on the date his
or her service terminates. Messrs. Broderick and Paul Cohen have previously been
granted options to purchase 30,000 shares of common stock exercisable at $3.00
per share. Mr. Cohen also received an option to purchase 50,000 shares of common
stock exercisable at $3.00 per share in connection with a one-year consulting
agreement dated November 1, 1997.


Executive Compensation

      The following table sets forth the compensation earned for the three
fiscal years ended December 31, 1998 to Mr. Mandelbaum, our Chairman and Chief
Executive Officer, to Mr. Messina, our President, and to Todd Cohen, our former
President. No other officer of Intelli-Check received compensation during any of
those fiscal years in excess of $100,000.


                           SUMMARY COMPENSATION TABLE
                                                                   Long-Term
                                        Annual Compensation      Compensation
                                      -----------------------  -----------------
                                                                 Securities
                                                                Underlying
Name And Principal Position           Year(s)      Salary ($)   Options/SARS (#)
- ---------------------------           ------        --------    --------------
Frank Mandelbaum.....................  1998         150,000         50,000
Chairman & CEO                         1997         150,000             --
                                       1996          75,000             --
Kevin Messina........................  1998        150,000              --
President                              1997         150,000         50,000
                                       1996          37,500             --
Todd Cohen...........................  1998          50,000         15,000
Former President                       1997         150,000         50,000
                                       1996          37,500             --


      The options shown above were granted under the 1998 Stock Option Plan, are
exercisable at $3.00 per share, and generally expire five years after the date
of grant. Mr. Cohen's options expire on August 15, 2000.

      Messrs. Mandelbaum and Messina have Employment Agreements expiring
December 31, 2001, which provide for base annual salaries of $225,000, subject
to specified conditions. Because of our limited resources, Messrs. Mandelbaum
and Messina have from time to time agreed to defer the receipt of substantial
portions of their salaries. In May 1999, Mr. Mandelbaum's deferred salary was
reduced by $150,000 by the issuance to him of 75,000 shares of our common stock
and warrants entitling him to purchase an additional 75,000 shares of our common
stock at a price of $3.00 per share at any time prior to May 3, 2001. In May
1999, Mr. Messina's deferred salary was reduced by $10,126 through the issuance
to him of 5,063 shares of our common stock and warrants to purchase 5,063 shares
of our common stock at a purchase price of $3.00 per share at any time prior to
May 3, 2001. As of June 30, 1999, Mr. Mandelbaum's deferred salary was
approximately $375,000, Mr. Messina's deferred salary was approximately $200,000
and Mr. Todd Cohen's deferred salary was approximately $110,000. In June 1999,
Mr. Messina received, in lieu of all deferred salary,


                                       25
<PAGE>


options to purchase 207,000 shares of common stock at an exercise price of $3.00
per share. Also in June 1999, Mr. Mandelbaum received, in lieu of all deferred
salary, options to purchase 375,000 shares of common stock at an exercise price
of $3.00 per share.

      Mr. Cohen resigned as President in April 1998. In June 1999, Mr. Cohen
received, in lieu of all deferred salary, options to purchase 110,000 shares of
common stock at an exercise price of $3.00.

      All the options granted in exchange for deferred salary expire five years
after the date of grant.

      The following table summarizes options granted during the year ended
December 31, 1998 to the named executive officers:

<TABLE>
<CAPTION>


                                                                                           Potential
                                                                                          Realizable
                                                                                           Value at
                                              Individual Grants                         Assumed Annual
                             --------------------------------------------------            Rates of
                              Number of  % of Total                                       Stock Price
                             Securities    Options                                      Appreciation for
                             Underlying  Granted to                                        Option Term
                               Options  Employees in  Exercise     Expiration       ------------------------
Name                           Granted   Fiscal Year   Price          Date              5%             10%
- -----                        ---------- ------------   -------      ---------           ---           ----
<S>                           <C>        <C>          <C>           <C>              <C>             <C>

Frank Mandelbaum..........     50,000       91%       $3.00          9/04/03         $41,442         $91,577
</TABLE>


      These options were granted pursuant to our 1998 Stock Option Plan. The
options granted to Mr. Mandelbaum are fully vested. During the year ended
December 31, 1998, we granted employees other than Mr. Mandelbaum options to
purchase 5,000 shares of common stock under the 1998 Stock Option Plan.

      The amounts shown as potential realizable value represent hypothetical
gains that could be achieved for the respective options if exercised at the end
of the option term. The 5% and 10% assumed annual rates of compounded stock
price appreciation are mandated by rules of the Securities and Exchange
Commission and do not represent our estimate or projection of our future common
stock prices. These amounts represent certain assumed rates of appreciation in
the value of our common stock from the fair market value on the date of grant.
Actual gains, if any, on stock option exercises are dependent on the future
performance of the common stock and overall stock market conditions. The amounts
reflected in the table may not necessarily be achieved.

      Pursuant to their employment agreements, Messrs. Mandelbaum and Messina
each received a grant in August 1999 of options to purchase 75,000 shares of our
common stock at a purchase price of $3.00 per share. Each of the options become
exercisable with respect to 25,000 shares of our common stock on January 1,
2000, an additional 25,000 shares of our common stock on January 1, 2001, and
the final 25,000 shares of our common stock on January 1, 2002. The options
expire five years from the date of grant.


Employment Agreements

      Effective January 1, 1999, Mr. Mandelbaum and Mr. Messina each entered
into a three-year employment agreement with Intelli-Check. Each of the
agreements provides for a base salary of $225,000. However, until such time as
we receive payment for gross sales of at least $1,000,000, the salaries are
capped at $150,000. The agreements also provide for the payment of a bonus if
our sales exceed $2,000,000 in the previous year. The bonus will be in the
amount of $50,000 plus 1% of the amount of sales in excess of $2,000,000 in each
year. In addition, for each fiscal year ending during the term of the employment
agreements, we will grant to each of the executives an option to purchase the
greater of 25,000 shares of our common stock at fair market value on the date of
grant or 10,000 shares of our common stock at fair market value on the date of
grant for each full $250,000 by which pre-tax profits for each year exceeds
pre-tax profits for the prior fiscal year. However, we are not required to grant
options to purchase more than 150,000 shares of our common stock with respect to
any one fiscal year.

      If there shall occur a change of control, as defined in the employment
agreement, the employee may terminate his employment at any time and be entitled
to receive a payment equal to 2.99 times his average annual compensation,
including bonuses, during the three years preceding the date of termination,
payable in cash to the extent of three months' salary and the balance in shares
of our common stock based on a valuation of $2.00 per share. Included within the
definition of change of control is the first day on which a majority of the
directors of the company do not consist of individuals recommended by Messrs.
Mandelbaum, Messina and one outside director.


                                       26
<PAGE>


      We have entered into a two-year employment agreement with Mr. Winiarz,
which became effective on September 7, 1999. The agreement provides for a base
salary of $125,000. In addition, we granted Mr. Winiarz an option to purchase
50,000 shares of common stock, of which 10,000 options are immediately
exercisable at $5.00 per share, 20,000 options are immediately exercisable at
$7.00 per share and 20,000 options will become exercisable on September 7, 2000
at $7.00 per share.

      We entered into a two-year employment agreement with Mr. Holloway, which
became effective on October 25, 1999. The agreement provides for a base salary
of $115,000. In addition, we granted Mr. Holloway an option to purchase 50,000
shares of common stock at $7.00 per share, of which 20,000 shares are
immediately exercisable and 5,000 shares become exercisable for each 10,000
sales of ID-Check products sold that exceed 10,000. The maximum options that can
be earned in any calendar year may not exceed 100,000. Any options earned above
the initial 50,000 options will be at fair market value on the date of grant.

      Under the terms of the agreements, each of the executives has the right to
receive his compensation in the form of shares of common stock valued at 50% of
the closing bid price of our shares of common stock as of the date of the
employee's election, which is to be made at the beginning of each quarter. In
addition, each of the employment agreements requires the executive to devote
substantially all his time and efforts to our business and contains
non-competition and nondisclosure covenants of the officer for the term of his
employment and for a period of two years thereafter. Each employment agreement
provides that we may terminate the agreement for cause.


Stock Option Plans

      1998 Stock Option Plan. Our 1998 Stock Option Plan was adopted by the
Board of Directors and stockholders in June 1998. Up to 400,000 shares of our
common stock have been authorized and reserved for issuance under the plan.
Under the plan, options may be granted in the form of incentive stock options or
non-qualified stock options from time to time to employees, officers, directors
and consultants of Intelli-Check, as determined by the compensation committee of
the board of directors. The compensation committee determines the terms and
conditions of options granted under the plan, including the exercise price. The
plan provides that the committee must establish an exercise price for incentive
stock options that is not less than the fair market value per share at the date
of the grant. However, if incentive stock options are granted to persons owning
more than 10% of the voting stock of Intelli-Check, the plan provides that the
exercise price must not be less than 110% of the fair market value per share at
the date of the grant. Each option must expire within five years of the date of
the grant. There are currently 340,000 immediately exercisable options
outstanding which have been granted under the plan, all of which are exercisable
at $3.00 per share.

      1999 Stock Option Plan. Our 1999 Stock Option Plan was adopted by the
Board of Directors and stockholders in August 1999. Up to 1,000,000 shares of
our common stock have been authorized and reserved for issuance under the plan.
Under the plan, options may be granted in the form of incentive stock options or
non-qualified stock options from time to time to employees, officers, directors
and consultants of Intelli-Check, as determined by the compensation committee of
the board of directors. The compensation committee determines the terms and
conditions of options granted under the plan, including the exercise price. The
plan provides that the committee must establish an exercise price for incentive
stock options that is not less than the fair market value per share at the date
of the grant. However, if incentive stock options are granted to persons owning
more than 10% of the voting stock of Intelli-Check, the plan provides that the
exercise price must not be less than 110% of the fair market value per share at
the date of the grant. Each option must expire within five years of the date of
the grant. There are currently 360,000 options outstanding which have been
granted under the plan, 10,000 are immediately exercisable at $5.00 per share
and 42,500 are immediately exercisable at $7.00 per share. The other 307,500,
upon vesting over a period of years, will be exercisable at prices ranging from
$3.00 - $7.00 per share.


Limitation on Liability and Indemnification Matters

      As authorized by the Delaware General Corporation Law, our certificate of
incorporation provides that none of our directors shall be personally liable to
us or our stockholders for monetary damages for breach of fiduciary duty as a
director, except for liability for:


                                       27
<PAGE>


      o    any breach of the director's duty of loyalty to our company or its
           stockholders

      o    acts or omissions not in good faith or which involve intentional
           misconduct or a knowing violation of law

      o    unlawful payments of dividends or unlawful stock redemptions or
           repurchases o any transaction from which the director derived an
           improper personal benefit


      This provision limits our rights and the rights of our stockholders to
recover monetary damages against a director for breach of the fiduciary duty of
care except in the situations described above. This provision does not limit our
rights or the rights of any stockholder to seek injunctive relief or rescission
if a director breaches his duty of care. In addition, our certificate of
incorporation provides that if the Delaware General Corporation Law is amended
to further limit the liability of a director, then the liability of the
directors shall be eliminated or limited to the fullest extent permitted by such
amendment. These provisions will not alter the liability of directors under
federal securities laws.

      Our certificate of incorporation further provides for the indemnification
of any and all persons who serve as our director, officer, employee or agent to
the fullest extent permitted under the Delaware General Corporation Law.

      Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to our directors, officers and controlling persons pursuant
to the foregoing provisions, or otherwise, we have been advised that in the
opinion of the SEC such indemnification is against public policy as expressed in
the Securities Act, and is, therefore, unenforceable.


                                       28
<PAGE>


                       PRINCIPAL AND SELLING STOCKHOLDERS

      The following table sets forth, as of the date of this prospectus and as
adjusted to reflect the sale by us of the 1,000,000 shares of common stock
offered under this prospectus, certain information regarding beneficial
ownership of Intelli-Check's common stock by each person who is known by us to
beneficially own more than 5% of our common stock and each other person for
whose benefit we are registering shares of common stock. The table also
identifies the stock ownership of each of our directors, each of our officers,
and all directors and officers as a group. Except as otherwise indicated, the
stockholders listed in the table have sole voting and investment powers with
respect to the shares indicated.
      Unless otherwise indicated, the address for each of the named individuals
is c/o Intelli-Check, Inc., 775 Park Avenue, Huntington, New York 11743.
      Shares of common stock which an individual or group has a right to acquire
within 60 days pursuant to the exercise or conversion of options, warrants or
other similar convertible or derivative securities are deemed to be outstanding
for the purpose of computing the percentage ownership of such individual or
group, but are not deemed to be outstanding for the purpose of computing the
percentage ownership of any other person shown in the table.
      The applicable percentage of ownership is based on 5,271,152 shares
outstanding as of the date of this prospectus and 6,271,152 shares to be
outstanding upon consummation of this offering, but does not include shares to
be issued if the over-allotment option is exercised.

<TABLE>
<CAPTION>



                                       Shares Beneficially Owned                             Shares Owned
                                            Prior to Offering                               After Offering
                                        ------------------------                        ---------------------
                                         Number          Percent      Shares Offered      Number      Percent
                                        --------        --------      --------------     --------    --------
<S>                                    <C>              <C>           <C>               <C>          <C>


Selling Stockholders:
  Jesup & Lamont Securities Corp..         15,000           *             15,000               --        --
  Allan Binder....................         10,000           *             10,000               --        --

Executive Officers, Directors &
5% Stockholders:

  Frank Mandelbaum................      1,322,000        22.5                 --        1,322,000       19.3
  Kevin Messina...................      1,417,000        25.2                 --        1,417,000       21.4
  Edwin Winiarz...................         30,000           *                 --           30,000         *
  W. Robert Holloway..............         20,000           *                 --           20,000         *
  Paul Cohen......................        281,385         5.2                 --         281,385         4.4
  Anthony Broderick...............         45,000           *                 --           45,000         *
  Evelyn Berezin..................         15,000           *                 --           15,000         *
  Charles McQuinn.................         15,000           *                 --           15,000         *
  Todd Cohen......................      1,150,000        21.1                 --        1,150,000       17.8
  New York State Science and
    Technology Foundation.........        550,000        10.2                 --          550,000       8.6
  All executive officers
    and directors
    as a group (8 persons)........      3,145,385        48.5                 --        3,145,385       42.0
</TABLE>


- -----------
*Indicates beneficial ownership of less than one percent of the total
outstanding common stock.

      The amounts shown for Jesup & Lamont Securities Corp. include the
currently exercisable right to acquire 7,500 units at $2.25 per unit. Each unit
consists of one share and a warrant to acquire an additional share at $3.00 per
share. Jesup & Lamont Securities Corp.'s address is 650 Fifth Avenue, New York,
NY 10019.

      Mr. Binder's address is 577 Old Country Road, Dix Hills, NY 11746.

      The amounts shown for Mr. Mandelbaum do not include 50,000 shares held by
Mr. Mandelbaum's wife, for which Mr. Mandelbaum disclaims beneficial ownership.

      The amounts shown for Mr. Paul Cohen do not include 25,000 shares held by
Mr. Cohen's wife and 2,500 shares held by Mr. Cohen's daughter, for which Mr.
Cohen disclaims beneficial ownership.

      Mr. Todd Cohen's address is 5 Violet Drive, Huntington Station, New York
11746.


                                       29
<PAGE>


      The Executive Director of the New York State Science and Technology
Foundation is David Catalfano. The members of the Foundation's board of
directors are Charles A. Gargano, Charles E. Dorkey, III, Antonia Novello, David
H. Feinberg, Richard P. Mills, Anthony H.Gioia, Evelyn Berezin, George McNamee,
Calvin O. Butts, Walter L. Robb, Van C. Campbell and Morris Stoler. Each of
these individuals may be considered a controlling person of the Foundation. The
address for the Foundation and each of these individuals is 99 Washington
Avenue, Albany, NY 12210, except for Ms. Berezin, who is also a director of
Intelli-Check. Her address is Intelli-Check's address shown above.

      The amounts shown in the table above for the following persons include the
right to acquire the number of shares shown pursuant to currently exercisable
stock options and/or warrants at the exercise price shown:

<TABLE>
<CAPTION>

Name                                                       No. of Shares         Exercise Price
- -----                                                      -------------         --------------
<S>                                                         <C>                   <C>

Frank Mandelbaum........................................      596,000                 $3.00
Kevin Messina...........................................      357,000                 $3.00
Edwin Winiarz...........................................       10,000                 $5.00
Edwin Winiarz...........................................       20,000                 $7.00
W. Robert Holloway......................................       20,000                 $7.00
Paul Cohen..............................................      135,000                 $3.00
Anthony Broderick.......................................       45,000                 $3.00
Evelyn Berezin..........................................       15,000                 $3.00
Charles McQuinn.........................................       15,000                 $3.00
Todd Cohen..............................................      175,000                 $3.00
New York State Science and Technology Foundation........      100,000                 $3.00
</TABLE>



                              CERTAIN TRANSACTIONS

      In October 1994, Messrs. Todd Cohen and Kevin Messina co-founded
Intelli-Check and each purchased 975,000 shares of common stock for $975. In
April 1998, Mr. Todd Cohen resigned as an officer of our company for personal
reasons and in August 1999, he completed his term as a director.

      In June 1996, Mr. Messina's company, K.M. Software, assigned two
copyrights covering certain software employed by ID-Check and a patent
application covering the ID-Check technology to Intelli-Check for an agreement
to pay $98,151 plus interest. The agreement also gave K.M. Software, or its
successor, the right to reclaim the rights to the copyrights and the patent
under certain specified conditions. In May 1999, the prior agreement was
superseded and in exchange Mr. Messina received 69,937 shares of our common
stock and warrants to purchase 69,937 shares of our common stock, at $3.00 per
share, exercisable at any time prior to May 3, 2001. The May 1999 agreement
provides for the payment by Intelli-Check of royalties equal to 0.005% of gross
sales from $2,000,000 to $52,000,000 and 0.0025% of gross sales in excess of
$52,000,000. Also, in May 1999, Mr. Messina's deferred salary was reduced by
$10,126 through the issuance to him of 5,063 shares of our common stock and
warrants to purchase 5,063 shares of our common stock at a purchase price of
$3.00 per share at any time prior to May 3, 2001. In June 1999, the balance of
Mr. Messina's deferred salary was reduced to zero by the issuance of options to
purchase 207,000 shares of our common stock at a purchase price of $3.00 per
share at any time prior to June 30, 2004.

      In June 1996, Frank Mandelbaum, Intelli-Check's Chief Executive Officer
and Chairman of the Board of Directors, purchased 950,000 shares of common stock
for $50,000. From time to time since then, Mr. Mandelbaum loaned money to
Intelli-Check totaling $142,000. In November 1997, Mr. Mandelbaum converted his
outstanding loans into 71,000 shares of our common stock and warrants to
purchase 71,000 shares of our common stock at $3.00 per share expiring on June
30, 2000. In May 1999, Mr. Mandelbaum's deferred salary was reduced by $150,000
through the issuance to him of 75,000 shares of our common stock and warrants to
purchase 75,000 shares of our common stock at a purchase price of $3.00 per
share at any time prior to May 3, 2001. In June 1999, Mr. Mandelbaum's deferred
salary was reduced to zero by the issuance of options to purchase 375,000 shares
of our common stock at an exercise price of $3.00 per share at any time prior to
June 30, 2004.


                                       30
<PAGE>


      In November 1997, one of our directors, Paul Cohen, received an option to
purchase 50,000 shares of common stock exercisable at $3.00 per share in
connection with a one-year consulting agreement. Also in November 1997, Mr.
Cohen's wife purchased 25,000 units consisting of one share of common stock and
one warrant to purchase an additional share of common stock for $3.00 in
connection with one of our private placements. The purchase price was $50,000.
In August 1999, Mr. Cohen purchased one unit in connection with our most recent
private placement. The unit consists of a promissory note having a principal
amount of $50,000, bearing interest at the annual rate of 10% and a warrant to
purchase 2,500 shares of our common stock for $3.00 per share.

      In June 1999, all deferred compensation due to Todd Cohen, our former
President and director, was eliminated by the issuance of options to purchase
110,000 shares of our common stock at an exercise price of $3.00 per share at
any time prior to June 30, 2004.


                            DESCRIPTION OF SECURITIES

Common Stock

      Our company is authorized to issue up to 20,000,000 shares of common
stock, $.001 par value. Common stockholders are entitled to one vote for each
share held of record on each matter submitted to a vote of stockholders. Common
stockholders are entitled to receive proportionately any dividends which may be
declared on the common stock by the board of directors. Upon the liquidation of
Intelli-Check, common stockholders are entitled to share proportionately in all
assets remaining after payment of liabilities and after providing for each class
of stock, if any, having preference over common stock. Common stockholders do
not have any priority right over others to purchase securities we may issue in
the future. They also do not have any right to convert their common stock into
any other securities.


Preferred Stock

      Intelli-Check is authorized to issue up to 1,000,000 shares of preferred
stock, $.01 par value per share. In January 1998, the New York State Science and
Technology Foundation converted our promissory note in the amount of $250,000
into 125,000 shares of series A convertible preferred stock. Also in January, we
sold 125,000 shares of preferred stock to the Foundation for $250,000. The
preferred stock was convertible into common stock at any time at the initial
conversion rate of one for one. In July 1999, the Foundation exercised its
conversion rights and received 250,000 shares of common stock in exchange for
its preferred stock.

      The Board of Directors may issue additional shares of preferred stock in
the future. The preferred stock may be issued in one or more series, the terms
of which may be determined at the time of issuance by the Board of Directors,
without further action by stockholders. These rights may include special voting
rights, preferences as to dividends and liquidation, conversion and redemption
rights and sinking fund provisions. Additional rights granted to future holders
of preferred stock could be used to restrict our company's ability to merge with
or sell its assets to a third party, thereby preserving control by present
owners.


Warrants


      From time to time in connection with financings used to fund our
development, we have issued warrants to purchase our common stock. As of
November 11, 1999, there were warrants outstanding to purchase 888,500 shares of
our common stock expiring on June 30, 2000 and warrants outstanding to purchase
892,600 shares of our common stock expiring on various dates up to August 2002.
Each warrant entitles the holder to purchase one share of common stock for
$3.00. If certain circumstances occur, we have the right to redeem the
outstanding warrants at a price of $.01 per warrant on not less than 20 days
written notice if the last sale price of the common stock has averaged at least
$4.50 per share for the 20 consecutive trading days ending at least five days
prior to the date on which notice is given for some of the warrants and $6.00
per share for certain other warrants.



                                       31
<PAGE>


Registration Rights

      Allan Binder, who holds 10,000 shares of common stock, is entitled to
piggyback registration rights, under the Securities Act, with respect to those
shares. Jesup & Lamont Securities Corp., which holds a warrant to purchase 7,500
units, each of which consists of one share of common stock and an additional
warrant to purchase one share of common stock, is entitled to piggyback
registration rights with respect to those 15,000 shares. These 25,000 shares are
being registered under this prospectus. In connection with this offering, we
have agreed to grant to the underwriters certain demand and piggyback
registration rights in connection with the 100,000 shares of common stock
issuable upon exercise of the underwriters' warrants.

      In addition, the holders of warrants to purchase 60,000 shares of our
common stock are entitled to piggyback registration rights and one demand
registration right under specified conditions. The demand registration right is
exercisable at any time from one year to five years after the effective date of
this prospectus by the holders of warrants exercisable into a majority of the
shares. The piggyback registration rights become effective after this offering.

Delaware Anti-Takeover Law

      We are subject to the provisions of Section 203 of the Delaware General
Corporation Law. That section requires the vote of at least two-thirds of the
outstanding voting stock of a company not owned by an interested stockholder to
approve certain business combinations. Section 203 defines interested
stockholder as any entity or person owning 15% or more of the outstanding voting
stock of the company and any entity or person affiliated with, controlling on
controlled by such entity or person. As a result, this statute may discourage
attempts to acquire Intelli-Check, including attempts that might result in a
premium over the market price for the shares of common stock held by
stockholders.

      Our by-laws provide that stockholders must comply with an advance notice
procedure for the nomination of candidates for election as directors as well as
for other stockholder proposals to be considered at annual meetings of
stockholders. In general, notice of intent to nominate a director or raise
matters at annual meetings will have to be received by us. These provisions may
preclude stockholders from bringing matters before an annual meeting of
stockholders or from making nominations for directors.

      The authorized but unissued shares of common stock and preferred stock are
available for future issuance without stockholder approval. These additional
shares may be utilized for a variety of corporate purposes, including future
public offerings to raise additional capital, corporate acquisitions and
employee benefit plans. The existence of authorized but unissued shares of
common stock and preferred stock could render more difficult or discourage an
attempt to obtain control of Intelli-Check by means of a proxy contest, tender
offer, merger or otherwise.

Transfer Agent and Warrant Agent

      The transfer agent for the common stock and the warrant agent for the
underwriters' warrants is Continental Stock Transfer & Trust Company.

                         SHARES ELIGIBLE FOR FUTURE SALE

      Immediately after the closing of this offering, we will have 6,271,152
shares of common stock issued and outstanding. Of this total, 1,010,000 shares
registered hereby together with 1,164,500 shares previously issued and held for
more than two years will be freely tradeable without restriction or further
registration under the Securities Act of 1933, as amended, except for any shares
purchased by an "affiliate" of our company (in general, a person who has a
controlling position with regard to the company). Shares held by an affiliate
will be subject to the resale limitations of Rule 144 under the Securities Act.

      All of the remaining 4,096,652 shares of common stock currently
outstanding are "restricted securities". These shares will become eligible for
sale at various times beginning 90 days following the date of this prospectus
when 394,605 shares will be eligible to be sold, and the balance of the
restricted shares will become eligible for sale at various times beginning April
2, 2000, subject to the contractual provisions described below.

      In addition, there are 3,873,100 shares subject to currently outstanding
options or warrants, or reserved for future issuance.


                                       32
<PAGE>



      The market price of our common stock could decline as a result of sales of
a large number of shares of common stock in the market after this offering, or
the perception that these sales may occur. These sales also might make it more
difficult for us to sell equity securities in the future at a time and at a
price that we deem appropriate.


      In addition, we have granted certain demand and piggyback registration
rights to the underwriters with respect to the shares of common stock issuable
upon exercise of the underwriters' warrants.

      Our officers, directors and 5% shareholders have agreed not to sell or
otherwise dispose of any shares of common stock or exercise any registration
rights for a period not to exceed twelve months following the date of this
prospectus without the underwriters' prior written consent. Upon the expiration
of the twelve-month period, 3,358,447 shares of our common stock will become
eligible for sale, in some cases subject to volume restrictions under Rule 144.

      We cannot predict the effect, if any, that market sales of common stock or
the availability of such shares for sale will have on the market price
prevailing from time to time. Nevertheless, the possibility that substantial
amounts of common stock may be sold in the public market may adversely affect
prevailing market prices for the common stock and could impair our company's
ability to raise capital through the sale of its equity securities.

                                  UNDERWRITING

      The underwriters named below have severally agreed, subject to the terms
and conditions contained in the underwriting agreement relating to this
offering, to purchase from our company the number of shares set forth opposite
their names below:


         Name                                              Number of Shares
         -----                                             ----------------
GunnAllen Financial, Inc.............................
Starr Securities, Inc................................
                                                              ---------
  Total..............................................         1,000,000
                                                              =========


      The underwriting agreement provides that the obligations of the
underwriters are subject to approval of certain legal matters by counsel and to
various other conditions. The nature of the underwriters' obligations is such
that they are committed to purchase and pay for all of the shares of common
stock if any are purchased.

      The underwriters have advised us that they propose to offer the shares of
common stock to the public at the public offering price set forth on the cover
page of this prospectus. The underwriters may allow certain dealers who are
members of the NASD concessions, not in excess of $_____ per share, of which not
in excess of $______ per share may be reallowed to other dealers who are members
of the NASD.


      We have granted to the underwriters an option, exercisable not later than
30 days after the date of this prospectus, to purchase up to 150,000 shares at
the public offering price set forth on the cover page of this prospectus, less
underwriting discounts and commissions. The underwriters may exercise this
option only to cover over-allotments, if any, made in connection with the sale
of the shares of common stock offered by this prospectus. If the underwriters
exercise their over-allotment in full, the total price to the public would be
$8,625,000, the total underwriting discounts and commissions would be $776,250
and the total proceeds (before payment of the expenses of this offering) to our
company would be $7,848,750.

      We have agreed to pay to the underwriters a non-accountable expense
allowance equal to 3% of the gross proceeds derived from the sale of the shares
offered by this prospectus, including any securities sold prior to the
underwriters' over-allotment option, $30,000 of which has been paid as of the
date of this prospectus. We have also agreed to pay all expenses in connection
with qualifying the shares offered under the laws of such states as the
underwriters may designate, including expenses of counsel retained for such
purpose by the underwriters. We estimate the expenses of this offering to be
$661,500 or $695,250 if the underwriter's overallotment option is exercised in
full.


      We retained GunnAllen Financial as a consultant for the period March 1999
through June 1999. GunnAllen Financial received a fee consisting of a warrant to
purchase 50,000 shares of our common stock at an exercise price of $3.00 per
share, expiring March 24, 2002. Under this agreement, GunnAllen Financial
provided us general financial advisory services.


                                       33
<PAGE>

      GunnAllen Financial acted as placement agent for the $1,200,000 private
placement made by us in August and September, 1999 and received a commission of
$120,000 for its services. GunnAllen Financial has been appointed as our agent
for the exercise of our outstanding warrants and will receive a fee of 5% of the
exercise price if we redeem the warrants within twelve months of the date of
this prospectus.


      At the closing of this offering, we will sell to the underwriters and
their designees, for an aggregate of $100, underwriters' warrants to purchase up
to 100,000 shares of common stock. The underwriters' warrants are exercisable at
any time, in whole or in part, during the four-year period commencing one year
from the date of this prospectus, at an exercise price of $8.25 per share (110%
of the public offering price per share). The underwriters' warrants are only
assignable or transferable to the officers and partners of the underwriters and
members of the selling group for one year following the date of this prospectus.
During the exercise period, the holders of the underwriters' warrants will have
the opportunity to profit from a rise in the market price of the common stock,
which will dilute the interests of our stockholders. We expect that the
underwriters' warrants will be exercised when we would, in all likelihood, be
able to obtain any capital needed on terms more favorable than those provided by
the underwriters' warrant. Any profit realized by the underwriters on the sale
of the underwriters' warrants, the underlying shares of common stock may be
deemed additional underwriting compensation. The underwriters' warrants contain
a cashless exercise provision.


      For a period of three years from the date of this prospectus, the
underwriters will have a right of first refusal with respect to any private
placements or underwriting of any future public offerings of our securities.

      We have agreed that, upon the request of the holders of the majority of
the underwriters' warrants, we will (at our own expense), on one occasion during
the exercise period, register the underwriters' warrants and the shares of
common stock underlying the underwriters' warrants under the Securities Act. We
have also agreed to include the underwriters' warrants and all such underlying
shares of common stock in any appropriate registration statement which is filed
by us under the Securities Act during the five years following the date of this
prospectus.

      We have agreed, for a period of three years from the date of this
prospectus, that the underwriters shall have the option to designate one
individual as a non-voting adviser to our board of directors to attend any and
all board and board committee meetings. The underwriters have not yet exercised
and currently do not intend to exercise their right to designate such a person
in the near future.

      All of our officers, directors and our 5% stockholders have agreed not to
sell or otherwise dispose any of their shares in the public markets for a period
of twelve months from the date of this prospectus without the underwriters'
prior written consent.

      The underwriters have informed us that they do not expect sales of the
securities offered to discretionary accounts to exceed 1% of the shares offered
by this prospectus.

      We have agreed to indemnify the underwriters against certain civil
liabilities, including liabilities under the Securities Act. We have been
advised that, in the opinion of the SEC, indemnification for liabilities arising
under the Securities Act is against public policy as expressed in the Securities
Act and is, therefore, unenforceable.

      Before this offering there has been no public market for the common stock.
Accordingly, the initial public offering price of the common stock has been
determined by negotiation between us and the underwriters and may not
necessarily be related to our asset value, net worth or other established
criteria of value. Factors to be considered in determining such price include
our financial condition and prospects, an assessment of our management, market
prices of similar securities of comparable publicly-traded companies, certain
financial and operating information of companies engaged in activities similar
to our business and the general condition of the securities market.

      In connection with this offering, the underwriters and selling group
members and their respective affiliates may engage in transactions that
stabilize, maintain or otherwise affect the market price of our common stock.
Such transactions may include stabilization transactions effected in accordance
with Regulation M of the Securities Exchange Act of 1934, pursuant to which such
persons may bid for or purchase common stock for the purpose of pegging, fixing
or maintaining the price of our common stock at a level that is higher than the
market would dictate in the absence of such transactions.


                                       34
<PAGE>

      The underwriters may also create a short position for the account of the
underwriters by selling more shares in connection with the offering than they
are committed to purchase from us, and in such case may purchase common stock in
the open market following the completion of the offering to cover all or a
portion of their short position. The underwriters may also cover all or a
portion of their short position, up to 150,000 shares, by exercising the
over-allotment option described above.

      In addition, the underwriters may also impose a "penalty bid" under
contractual arrangements whereby the underwriters may reclaim from a dealer
participating in the offering the selling concession with respect to shares that
are distributed in the offering but subsequently purchased for the account of
the underwriters in the open market.

      In general, any of the transactions described above may result in the
maintenance of the price of our common stock at a level above that which might
otherwise prevail in the absence of such transactions. We and the underwriters
make no representation or prediction as to the direction or magnitude of any
effect that such transactions may have on the price of our common stock. In
addition, we and the underwriters make no representation that the underwriters
will engage in such transactions or that such transactions, once commenced, will
not be discontinued without notice.

                                  LEGAL MATTERS

      The validity of the securities offered by this prospectus will be passed
upon for our company by Milberg Weiss Bershad Hynes & Lerach LLP, New York, New
York. Tenzer Greenblatt LLP has served as counsel to the underwriters in
connection with this offering.

                                     EXPERTS

      The financial statements of our company as of December 31, 1998, and for
the years ended December 31, 1997 and 1998, included in this prospectus and
registration statement have been audited by Arthur Andersen LLP, independent
public accountants, as indicated in their report with respect thereto, and are
included herein in reliance upon the authority of said firm as experts in giving
said report.


                             ADDITIONAL INFORMATION

      We have filed with the SEC the registration statement on form SB-2 under
the Securities Act with respect to the common stock offered by this prospectus.
This prospectus, which constitutes a part of the registration statement, does
not contain all of the information set forth in the registration statement and
the exhibits filed with it, portions of which have been omitted as permitted by
the rules and regulations of the SEC. For further information with respect to
our company and the securities offered by this prospectus, reference is made to
the registration statement and to the exhibits filed. Statements contained in
this prospectus regarding the content of any contract or other document referred
to are not necessarily complete. In each instance, we refer you to the copy of
such contract or other document filed as an exhibit to the registration
statement, and these statements are qualified in their entirety by such
reference to the contract or document.

      The registration statement, including all exhibits, may be inspected
without charge at the principal office of the SEC at Judiciary Plaza, 450 Fifth
Street, N.W., Washington, D.C. 20549, and at the SEC's regional offices located
at Seven World Trade Center, Suite 1300, New York, New York 10048 and Citicorp
Center, 500 West Madison Street, Suite 1400, Chicago, Illinois 60661. Copies of
these materials may also be obtained from the Public Reference Section of the
SEC at 450 Fifth Street, N.W., Room 1024, Washington, D.C. 20549, upon the
payment of prescribed fees. You may obtain information on the operation of the
Public Reference Room by calling the SEC at 1-800-SEC-0330. In addition,
registration statements and certain other filings made with the SEC through its
Electronic Data Gathering, Analysis and Retrieval systems are publicly available
through the commission's site on the World Wide Web located at
http://www.sec.gov. The registration statement, including all exhibits and
schedules thereto and amendments thereof, has been filed with the SEC through
the Electronic Data Gathering, Analysis and Retrieval system.

      Upon the closing of this offering, we will become subject to the reporting
requirements of the Securities Exchange Act and in accordance with these
requirements, will file reports, proxy statements and other information with the
SEC. We intend to furnish our stockholders with annual reports containing
audited financial statements and such other periodic reports as we deem
appropriate or as may be required by law.


                                       35
<PAGE>

                               INTELLI-CHECK, INC.

                          INDEX TO FINANCIAL STATEMENTS

                                                                         Page
                                                                         ----
Report of Independent Public Accountants ..........................      F-2

Financial Statements:

  Balance Sheets as of December 31, 1998 and
     September 30, 1999 (Unaudited) ...............................      F-3

  Statements of Operations for the Years Ended
     December 31, 1997 and 1998 and the Nine
     Months Ended September 30, 1998 and 1999 (Unaudited) .........      F-4

  Statements of Stockholders' (Deficit) Equity
     for the Years Ended December 31, 1997
     and 1998 and the Nine Months Ended
     September 30, 1999 (Unaudited) ...............................      F-5

  Statements of Cash Flows for the Years
     Ended December 31, 1997 and 1998
      and the Nine Months Ended September 30,
     1998 and 1999 (Unaudited) ....................................      F-6

Notes To Financial Statements .....................................   F-7 - F-17


                                      F-1
<PAGE>

                    REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS

      To the Stockholders of Intelli-Check, Inc.:

      We have audited the accompanying balance sheets of Intelli-Check,  Inc. (a
Delaware  corporation)  as of December 31, 1998,  and the related  statements of
operations, stockholders' (deficit) equity and cash flows for the two years then
ended.  These  financial  statements  are the  responsibility  of the  Company's
management.  Our  responsibility  is to express  an  opinion on these  financial
statements based on our audits.

      We conducted our audits in accordance  with  generally  accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

      In our opinion, the financial statements referred to above present fairly,
in all material respects,  the financial  position of Intelli-Check,  Inc. as of
December 31, 1998,  and the results of its operations and its cash flows for the
two  years  then  ended  in  conformity  with  generally   accepted   accounting
principles.

                                                             Arthur Andersen LLP

New York, New York
September 24, 1999


                                      F-2
<PAGE>

                               INTELLI-CHECK, INC.

                                 BALANCE SHEETS

                                                     December 31,  September 30,
                          ASSETS                         1998          1999
                                                     -----------   -------------
                                                                    (Unaudited)

Current Assets:

  Cash ............................................ $   159,600    $   762,239
  Inventory .......................................      16,693         15,894
  Deposit .........................................        --          423,905
  Other current assets ............................         921         11,247
                                                    -----------    -----------
      Total current assets ........................     177,214      1,213,285
Property and Equipment, net (Note 3) ..............     188,064        224,383
Patent Costs, net of accumulated amortization of
  $25,816 as of December 31, 1998
  and $30,473 as of September 30, 1999
  (unaudited) .....................................      79,845         75,188
Other Assets ......................................       6,180        154,500
                                                    -----------    -----------
      Total assets ................................ $   451,303    $ 1,667,356
                                                    ===========    ===========

     LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY

Current Liabilities:

  Accounts payable ...............................  $   243,351    $    59,902
  Accrued expenses ...............................      752,370        261,625
  Promissory notes (Note 10) .....................         --        1,200,000
  Note payable to related party (Note 5) .........       98,151           --
  Current portion of capital lease obligations ...        8,008         17,643
                                                    -----------    -----------

      Total current liabilities ..................    1,101,880      1,539,170
                                                    -----------    -----------
Capital Lease Obligations (Note 9) ...............        6,993         10,299
                                                    -----------    -----------
Commitments and Contingencies (Note 9)
Stockholders' Equity (Deficit):

  Series A  Convertible  Preferred
    Stock -- $.01 par value; .....................    1,000,000
    shares authorized; no shares
    issued and outstanding as of
    December 31, 1998 and September
    30, 1999 (unaudited), respectively ...........        2,500           --
  Common stock-- $.001 par value; 20,000,000
    shares  authorized; 4,402,552 and
    5,271,152 shares issued  and
    outstanding as of December 31, 1998 and
    September 30, 1999 (unaudited), respectively .        4,402          5,271
  Additional paid-in capital .....................      839,342      2,865,888
  Accumulated deficit ............................   (1,503,814)    (2,753,272)
                                                    -----------    -----------
      Total stockholders' (deficit) equity .......     (657,570)       117,887
                                                    -----------    -----------
      Total liabilities and stockholders'
          (deficit) equity .......................  $   451,303    $ 1,667,356
                                                    ===========    ===========

   The accompanying notes are an integral part of these balance sheets.


                                      F-3
<PAGE>

                               INTELLI-CHECK, INC.

                            STATEMENTS OF OPERATIONS

<TABLE>
<CAPTION>
                                      For the Years Ended         For the Nine Months Ended
                                           December 31                   September 30
                                    --------------------------    --------------------------
                                       1997           1998            1998          1999
                                    -----------    -----------    -----------    -----------
                                                                          (Unaudited)

<S>                                 <C>            <C>            <C>            <C>
Sales ...........................   $    16,736    $    86,354    $    86,354    $       327
Cost of Goods Sold ..............         4,343         22,074         22,074             55
                                    -----------    -----------    -----------    -----------
      Gross Profit ..............        12,393         64,280         64,280            272

Operating Expenses:
  Selling .......................       124,453        139,470        118,315        171,908
  General and administrative ....       992,375      1,060,537        585,887        914,239
  Research and development ......       462,804        306,608        122,597        127,999
                                    -----------    -----------    -----------    -----------
      Loss from operations ......    (1,567,239)    (1,442,335)      (762,519)    (1,213,874)

Other Income (Expenses):
  Interest Expense ..............       (37,057)       (61,479)       (23,248)       (35,584)
                                    -----------    -----------    -----------    -----------
                                     (1,604,296)    (1,503,814)      (785,767)    (1,249,458)
Income Tax Benefit (Note 2) .....          --             --             --             --
                                    -----------    -----------    -----------    -----------
      Net Loss ..................   $(1,604,296)   $(1,503,814)   $  (785,767)   $(1,249,458)
                                    ===========    ===========    ===========    ===========
Per Share Information:
  Net loss per common share--
    Basic and diluted ...........        $(0.46)        $(0.36)        $(0.19)        $(0.26)
                                    ===========    ===========    ===========    ===========
  Common shares used in computing
    per share amounts--
    Basic and diluted ...........     3,505,638      4,208,003      4,162,553      4,841,483
                                    ===========    ===========    ===========    ===========
</TABLE>

        The accompanying notes are an integral part of these statements.


                                      F-4
<PAGE>

                               INTELLI-CHECK, INC.

                  STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

                 For the Years Ended December 31, 1997 and 1998
            and the Nine Months Ended September 30, 1999 (Unaudited)


<TABLE>
<CAPTION>
                                                                           Series A
                                                     Common Stock        Preferred Stock    Additional
                                               ------------------      -----------------     Paid-in      Accumulated
                                               Shares      Amount      Shares     Amount     Capital         Deficit        Total
                                               ------      ------      ------     ------     -------         -------        -----

<S>                                          <C>          <C>                      <C>       <C>           <C>           <C>
Balance, January 1, 1997 .................   3,251,385    $ 3,251          --      $  --     $ 374,226     $ (626,119)   $ (248,642)
  Issuance of common stock ...............     885,500        886          --         --     1,666,963              --     1,667,849
  Net loss ...............................          --         --          --         --            --     (1,604,296)   (1,604,296)
                                             ---------    -------   ---------    -------    ----------   ------------     ----------
Balance, December 31, 1997 ...............   4,136,885      4,137          --         --     2,041,189     (2,230,415)     (185,089)
  Conversion from S Corporation to
    C Corporation ........................          --         --          --         --   (2,230,415)       2,230,415            --
Conversion of debt into Series A
  Preferred Stock ........................          --         --     125,000      1,250       248,750              --       250,000
Issuance of Series A Preferred Stock .....          --         --     125,000      1,250       248,750              --       250,000
Common stock issued for employee
  compensation ...........................       7,667          7          --         --        15,326              --        15,333
Issuance of common stock in private
  placement ..............................     258,000        258          --         --       515,742              --       516,000
Net loss .................................          --         --          --         --            --     (1,503,814)   (1,503,814)
                                             ---------    -------   ---------    -------    ----------   ------------     ----------
Balance, December 31, 1998 ...............   4,402,552      4,402     250,000      2,500       839,342     (1,503,814)     (657,570)
  Issuance of common stock in private
    placements ...........................     274,600        275          --         --       548,925              --       549,200
  Exercise of warrant ....................     100,000        100          --         --       199,900              --       200,000
  Issuance of common stock for note
    payable and interest .................      69,937         70          --         --       139,804              --       139,874
  Issuance of common stock for
    deferred salary ......................      80,063         80          --         --       160,046              --       160,126
  Issuance of common stock for
    settlements and accounts payable .....      94,000         94          --         --       275,621              --       275,715
  Issuance of stock options for
    deferred salary ......................          --         --          --         --       700,000              --       700,000
  Conversion of preferred stock ..........     250,000        250   (250,000)    (2,500)         2,250              --            --
  Net loss (unaudited) ...................          --         --          --         --            --     (1,249,458)   (1,249,458)
                                             ---------    -------   ---------    -------    ----------   ------------     ----------
Balance, September 30, 1999
  (unaudited) ............................   5,271,152    $ 5,271          --    $    --    $2,865,888   $ (2,753,272)    $  117,887
                                             =========    =======   =========    =======    ==========   ============     ==========
</TABLE>

        The accompanying notes are an integral part of these statements.


                                      F-5
<PAGE>

                               INTELLI-CHECK, INC.

                            STATEMENTS OF CASH FLOWS

<TABLE>
<CAPTION>
                                                                 For the Years Ended                For the Nine Months
                                                                    December 31                     Ended September 30
                                                           -------------------------------      -------------------------
                                                               1997               1998             1998          1999
                                                           ------------       ------------      ----------   ------------
                                                                                                       (Unaudited)
<S>                                                        <C>                <C>               <C>          <C>
Cash Flows From Operating Activities:
  Net loss .............................................   $(1,604,296)       $(1,503,814)      $(777,867)   $(1,249,458)
  Adjustments to reconcile net loss
    to net cash used in
    operating activities--
  Depreciation and amortization ........................        38,096             70,183          48,573        74,752
  Loss on disposal of assets ...........................            --            225,783              --            --
  Noncash compensation .................................            --             15,333              --            --
  Changes in assets and liabilities-
    (Increase) decrease in inventory ...................       (24,116)          (122,292)           5,036           799
    (Increase) in other current assets .................            --              (921)         (2,773)       (10,326)
    (Increase) in deposit ..............................            --                 --              --      (423,905)
    Decrease (increase) in other assets ................         1,679              5,531           4,733      (148,320)
    Increase (decrease) in accounts
      payable and accrued expenses .....................       423,651            262,172        (69,240)       503,370
                                                            ----------         ----------       ---------     ---------
      Net cash used in operating activities ............    (1,164,986)        (1,048,025)       (791,538)    (1,253,088)
                                                            ----------         ----------       ---------     ---------

Cash Flows From Investing Activities:
  Purchases of property and equipment ..................      (246,264)           (26,975)        (26,006)       (85,409)
                                                            ----------         ----------       ---------     ---------
     Net cash (used in) investing activities ...........      (246,264)           (26,975)        (26,006)       (85,409)
                                                            ----------         ----------       ---------     ---------

Cash Flows From Financing Activities:
  Net proceeds from issuance of common stock ...........     1,667,849            516,000         226,000       749,200
  Proceeds from issuance of preferred stock ............            --            250,000         250,000            --
  Repayment of capital lease obligations ...............            --           (13,170)        (14,657)        (8,063)
  (Repayments of) proceeds from notes payable ..........       250,000                 --              --            (1)
  (Repayments of) stockholder loans ....................       (88,809)                --              --            --
  Decrease in deferred financing  costs ................        37,500                 --              --            --
  Proceeds from promissory notes .......................            --                 --              --     1,200,000
                                                            ----------         ----------       ---------     ---------
      Net cash provided by financing activities ........     1,866,540            752,830         461,343     1,941,136
                                                            ----------         ----------       ---------     ---------
      Net increase (decrease) in cash ..................       455,290          (322,170)       (356,201)       602,639
CASH, beginning of period ..............................        26,480            481,770         481,770       159,600
                                                            ----------         ----------       ---------     ---------
CASH, end of period ....................................    $  481,770         $  159,600       $ 125,569     $ 762,239
                                                            ==========         ==========       =========     =========

Supplemental Disclosure of Cash Flow Information:
  Cash paid during the period for interest .............    $   30,800         $   14,603       $   9,000      $  1,660

Supplemental Disclosure of Noncash
  Financing Activities:
  Conversion of preferred stock to common stock ........            --                 --              --       250,000
  Conversion of debt to preferred stock ................            --            250,000         250,000            --
  Common stock issued to satisfy debt and
     notes payable .....................................       142,000                 --              --       139,874
  Common stock issued to satisfy deferred salary .......            --                 --              --       160,126
  Common stock issued for settlements
     and accounts payable ..............................            --                 --              --       275,715
  Stock options issued to satisfy  deferred salary .....            --                 --              --       700,000
  Capital lease obligations incurred ...................        28,171                 --              --        20,505
</TABLE>

        The accompanying notes are an integral part of these statements.


                                      F-6
<PAGE>

                              INTELLI-CHECK, INC.

                          NOTES TO FINANCIAL STATEMENTS

1. NATURE OF BUSINESS

      Intelli-Check, Inc. (the "Company") was incorporated in New York in
October 1994 to develop, manufacture and market an advanced document
verification system to enable a retailer to determine their customer's age and
identity. The system may be used to detect and prevent the use of fraudulent
identification for the purchase of alcohol, tobacco and other age-restricted
products; to reduce the risk to the retailer of substantial monetary fines,
criminal penalties and license revocation for the sale of age-restricted
products to minors; and to reduce check cashing, credit card and other types of
fraud.

      The Company has developed and patented the innovative software technology
that is included in the advanced document verification system terminal called
the "ID-Check." The ID-Check terminal, in which the Company's patented software
is loaded, was designed to offer convenient and reliable age and document
verification. The ID-Check reads, analyzes and displays the encoded information
contained on driver licenses and most other forms of accepted government issued
identification. In addition, the ID-Check product is capable of being upgraded
to accommodate changes made by the governmental issuers of driver licenses and
ID cards. The ID-Check terminal requires a quick swipe of the driver license or
ID card by the retailer; displays a "yes", "no", "expired" or "tampered"; and
creates a record of transactions as proof that the retailer has used proper due
diligence.

      During the fourth quarter of 1997, the Company commenced its principal
operations by realizing sales of pre-production prototypes of ID-Check. The
Company has completed its refinement of its software and has placed its initial
order for 525 units of its ID-Check terminal under a supplier agreement with a
third party (Note 10).

      Through December 31, 1998, the Company has incurred significant cumulative
losses and has a net capital deficiency as of December 31, 1998. In addition,
the Company's liquidity requirements have been and will continue to be
significant. Management has developed a detailed plan and has taken certain
actions in order to generate the funding necessary for the Company's operations,
including: (1) a plan for marketing and sales of the Company's product, ID-Check
(see above); (2) issuance of additional capital and debt (Note 10); (3) hiring
and retaining key employees (Notes 9 and 10); and (4) effective cost control.

2. SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

      The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.

Revenue Recognition

      Revenue on sales of the Company's product is recognized upon shipment to
the customer.

Inventory

      Inventory is stated at the lower of cost or market and cost is determined
using the first-in, first-out method. Inventory is comprised of finished goods.

Long-Lived Assets

      The Company's policy is to record long-lived assets at cost, amortizing
these costs over the expected useful life of the related assets, in accordance
with Statement of Financial Accounting Standards ("SFAS") No. 121, "Accounting
for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed
of." These


                                      F-7
<PAGE>

assets are reviewed for impairment whenever events or changes in circumstances
indicate that the carrying amounts of the assets may not be reasonable.
Furthermore, these assets are evaluated for continuing value and proper useful
lives by comparison to undiscounted expected future cash flow projections.

Property and Equipment

      Property and equipment are recorded at cost. All fixed assets are
depreciated over their estimated useful lives ranging from three to seven years
using the straight-line basis. Equipment held under capital leases is amortized
utilizing the straight-line method over the lesser of the term of the lease or
estimated useful life of the asset in accordance with SFAS No. 13, "Accounting
for Leases."

Patent Costs

      Patent costs, primarily consisting of legal costs, are amortized over a
period of 17 years.

Capitalized Software Development Costs

      SFAS No. 86, "Accounting for the Costs of Computer Software to Be Sold,
Leased or Otherwise Marketed," specifies that costs incurred internally in
creating a computer software product shall be charged to expense when incurred
as research and development until technological feasibility has been established
for the product. Software production costs for computer software that is to be
used as an integral part of a product or process shall not be capitalized until
both (a) technological feasibility has been established for the software and (b)
all research and development activities for the other components of the product
or process have been completed. During the fourth quarter of 1997, the Company
completed both (a) and (b), as described above; however, no capitalized costs
were incurred or recorded during the remainder of 1997 or 1998.

Income Taxes

      Prior to 1998, the Company had elected to be treated as a Subchapter S
Corporation for federal and state income tax purposes and, as a result, the
losses of the Company were passed through directly to the shareholders. The
Company did, however, remain liable for New York State Subchapter S income
taxes. During 1998, the Company's tax status changed from an S Corporation to a
C Corporation as a result of the issuance of the Series A Convertible Preferred
Stock on January 8, 1998 (Note 6).

      The Company accounts for income taxes under SFAS No. 109, "Accounting for
Income Taxes." Deferred tax assets and liabilities are recognized for the
estimated future tax consequences attributable to differences between the
financial statement carrying amounts of existing assets and liabilities and
their respective tax bases and net operating loss carryforwards. Deferred tax
assets and liabilities are measured using expected tax rates in effect for the
year in which those temporary differences are expected to be recovered or
settled. The Company has recorded a full valuation allowance for its deferred
tax assets as of December 31, 1998, due to the uncertainty of the realizability
of those assets.

Fair Value of Financial Instruments

      The carrying amounts of cash, accounts receivable and accounts payable
approximate fair value due to the short-term maturity of these instruments. The
carrying amounts of capital lease obligations, including current portions,
approximate fair value.

Business Concentrations and Credit Risk

      Financial instruments, which subject the Company to concentrations of
credit risk, consist primarily of cash. The Company maintains cash with only one
financial institution. The Company performs periodic evaluations of the relative
credit standing of this institution. The Company has had limited sales of
prototypes to a number of clients which are concentrated in the United States.
The Company performs ongoing credit evaluations, generally does not require
collateral, and establishes an allowance for doubtful accounts based upon
factors surrounding the credit risk of customers, historical trends and other
information. There were no customers that accounted for greater than 10% of
sales for the years ended December 31, 1997 and 1998, and in addition, no
customer accounted for greater than 10% of accounts receivable as of December
31, 1998.


                                      F-8
<PAGE>

Net Income (Loss) Per Common Share

      The Company computes net income (loss) per common share in accordance with
SFAS No. 128, "Earnings Per Share". Under the provisions of SFAS No. 128, basic
net income (loss) per common share ("Basic EPS") is computed by dividing net
income (loss) by the weighted average number of common shares outstanding.
Diluted net income (loss) per common share ("Diluted EPS") is computed by
dividing net income (loss) by the weighted average number of common shares and
dilutive common share equivalents then outstanding. SFAS No. 128 requires the
presentation of both Basic EPS and Diluted EPS on the face of the statements of
operations.

      Diluted EPS for the years ended December 31, 1997 and 1998 and for the
nine months ended September 30, 1998 and 1999, does not include the impact of
stock options then outstanding, as the effect of their inclusion would be
antidilutive.

Stock-Based Compensation

      In 1998, the Company adopted the provisions of SFAS No. 123, "Accounting
for Stock-Based Compensation," by continuing to apply the provisions of
Accounting Principles Board No. 25, "Accounting for Stock Issued to Employees,"
("APB No. 25") while providing the necessary pro forma disclosures as if the
fair value method had been applied.

Research and Development Costs

      Research and development costs are charged to expense as incurred.

Unaudited Interim Consolidated Financial Statements

      The unaudited consolidated financial information included herein for the
nine months ended September 30, 1998 and 1999, have been prepared in accordance
with generally accepted accounting principles for interim financial statements.
In the opinion of the Company, these unaudited financial statements, reflect all
adjustments necessary, consisting of normal recurring adjustments, for a fair
presentation of such data on a basis consistent with that of the audited data
presented herein. The results of operations for interim periods are not
necessarily indicative of the results expected for a full year.

Comprehensive Income

      In June 1997, the Financial Accounting Standards Board ("FASB") issued
SFAS No. 130, "Reporting Comprehensive Income." This statement establishes
standards for reporting and display of comprehensive income and its components
(revenues, expenses, gains and losses) in a full set of general-purpose
financial statements. The Company adopted this statement in 1998. The adoption
of this statement did not have an impact on the Company's financial condition or
results of operations. Accordingly, the Company's comprehensive net loss is
equal to its net loss for the years ended December 31, 1997 and 1998 and for the
nine months ended September 30, 1998 and 1999.

Segment Information

      In June 1997, the FASB issued SFAS No. 131, "Disclosures About Segments of
an Enterprise and Related Information." This statement establishes standards for
the way the public business enterprises report information about operating
segments in annual financial statements and requires that those enterprises
report selected information about operating segments in interim financial
reports issued to shareholders. The Company adopted this statement in 1998. In
the initial year of application, comparative information for earlier years must
be restated. Management has determined that it does not have any separately
reportable business segments.

Costs of Computer Software Developed or Obtained for Internal Use

      In April 1998, the American Institute of Certified Public Accountants
issued Statement of Position 98-1, "Accounting for the Costs of Computer
Software Developed or Obtained for Internal Use" ("SOP 98-1"), which provides
guidance for determining whether computer software is internal-use software and
guidance on accounting for the proceeds of computer software originally
developed or obtained for internal use and then subsequently sold to the public.
It also provides guidance on capitalization of the costs incurred for computer


                                      F-9
<PAGE>

software developed or obtained for internal use. SOP 98-1 is effective for
fiscal years beginning after December 31, 1998. The adoption of SOP 98-1 did not
have a material effect on the Company's financial statements.

Recently Issued Accounting Standards

      In June 1998, the FASB issued SFAS No. 133, "Accounting for Derivatives
and Hedging Activities," which establishes accounting and reporting standards of
derivative instruments, including certain derivative instruments embedded in
other contracts, and for hedging activities.

      In July 1999, the FASB issued SFAS No. 137, "Accounting for Derivative
Instruments and Hedging Activities -- Deferral of the Effective Date of FASB
Statement No. 133," which amends SFAS No. 133 to be effective for all fiscal
quarters of all fiscal years beginning after June 15, 2000. The Company does not
currently engage in derivative activity and does not expect the adoption of this
standard to have a material effect on the Company's results of operations,
financial position or cash flows.

Reclassifications

      Certain prior year amounts have been reclassified to conform to the
current year presentation.

3. PROPERTY AND EQUIPMENT

      Property and equipment are comprised of the following:

                                                     December 31,  September 30,
                                                        1998            1999
                                                     ------------  -------------
                                                                     (Unaudited)

Computer equipment ...........................         $103,676       $206,431
Furniture and fixtures .......................           95,443         97,778
Leasehold improvements .......................           63,820         64,452
Office equipment .............................            8,440          9,132
                                                       --------       --------
                                                        271,379        377,793
Less-- Accumulated depreciation ..............           83,315        153,410
                                                       --------       --------
                                                       $188,064       $224,383
                                                       ========       ========

      Depreciation expense for the years ended December 31, 1997 and 1998
amounted to $20,066 and $36,982, respectively, and for the nine months ended
September 30, 1998 and 1999 amounted to $16,331 and $70,095, respectively,
(unaudited).

4. ACCRUED EXPENSES

      Accrued expenses are comprised of the following:

                                                    December 31,   September 30,
                                                        1998           1999
                                                     -----------    ------------
                                                                     (Unaudited)

Payroll .....................................         $629,272        $ 16,656
Professional fees ...........................               --         122,500
Interest ....................................           82,738           3,000
Other .......................................           40,360         119,469
                                                      --------        --------
                                                      $752,370        $261,625
                                                      ========        ========

5. NOTE PAYABLE TO RELATED PARTY

      As of December 31, 1998, the Company was indebted to the President of the
Company under a note payable agreement in the amount of $98,151, which
represented the principal of the note. The note bore interest at 8% and during
1998, the due date was extended to the sooner of June 1999 or the receipt of the
proceeds


                                      F-10
<PAGE>

from a stock offering through either a Private Placement or an Initial Public
Offering ("IPO") that exceeds $3,000,000. Accrued interest on the note was
included in accrued expenses in the accompanying balance sheets. The note
payable and all accrued interest were repaid subsequent to December 31, 1998
(Note 10).

6. CONVERTIBLE SECURED DEMAND NOTE

      In January 1997, the Company entered into a Note Purchase Agreement with
the New York State Science and Technology Foundation (the "Foundation") pursuant
to which the Company issued a Convertible Promissory Note in the amount of
$250,000 and the Foundation agreed to invest an additional $250,000 through the
purchase of 125,000 shares of Series A Convertible Preferred Stock based upon
the Company raising a certain amount of additional capital. The Note bore
interest at 8% per annum and was converted into 125,000 shares of Series A
Convertible Preferred Stock in January 1998. In addition, the Foundation
purchased an additional 125,000 shares of Series A Convertible Preferred Stock
for $250,000 in cash, upon the closing of a private placement of the Company's
common stock in January 1998. The Series A Convertible Preferred Stock is
convertible into the Company's common shares on a one-for-one basis (Note 8).

7. INCOME TAXES

      No provision for U.S. federal or state income taxes has been recorded for
the years ended December 31, 1997 and 1998 and for the nine months ended
September 30, 1998 and 1999 (unaudited) as the Company has incurred an operating
loss.

      Deferred income taxes reflect the net tax effects of temporary differences
between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. Significant components of
the Company's deferred tax assets for federal and state income taxes are as
follows:

                                                  December 31,    September 30,
                                                      1998            1999
                                                  ------------    -------------
                                                                   (unaudited)
Deferred tax assets, net:
  Net operating loss carryforwards ............     $380,000         $880,000
  Depreciation ................................      (12,000)         (20,000)
  Other .......................................      (10,000)         (16,000)
  Less-- Valuation allowance ..................      358,000          844,000
                                                    --------         --------
      Deferred tax assets, net ................     $     --         $     --
                                                    ========         ========

      Realization of deferred tax assets is dependent upon future earnings, if
any. The Company has recorded a full valuation allowance against its deferred
tax assets since management believes that it is more likely than not that these
assets will be realized. No income tax benefit has been recorded for all periods
presented because of the valuation allowance.

      As of December 31, 1998 and September 30, 1999 (unaudited), the Company
had net operating loss carryforwards (NOL's) for federal income tax purposes of
approximately $950,000 and $2,200,000 (unaudited), respectively. There can be no
assurance that the Company will realize the benefit of the NOL's. The federal
NOL's are available to offset future taxable income and expire from 2009 through
2019 if not utilized. Under Section 382 of the Internal Revenue Code, these
NOL's may be limited due to ownership changes.

      In January 1998, as a result of the issuance of Series A Convertible
Preferred Stock, the Company's S Corporation status was terminated and the
Company began operations as a C Corporation. Accordingly, the Company became
subject to federal and state income taxes and the retained deficit of the
Company was transferred to additional paid-in capital.

      If the Company operated as a C corporation since January 1997, the pro
forma income tax benefit would have been approximately $642,000 (unaudited),
offset by a full valuation allowance. No pro forma adjustments are required for
the year ended December 31, 1998 and the nine months ended September 30, 1998
(unaudited) as the Company was operating as a C Corporation for the majority of
each period and the adjustment would be immaterial.


                                      F-11
<PAGE>

8. STOCKHOLDERS' EQUITY

Series A Convertible Preferred Stock

      In January 1997, the Board of Directors authorized the creation of a class
of Series A Convertible Preferred Stock with a par value of $.01. The Series A
Convertible Preferred Stock is convertible into an equal number of common shares
at the holder's option, subject to adjustment for anti-dilution. The holders of
Series A Convertible Preferred Stock are entitled to receive dividends as and if
declared by the Board of Directors. In the event of liquidation or dissolution
of the Company, the holders of Series A Convertible Preferred Stock are entitled
to receive all accrued dividends, if applicable, plus the liquidation price of
$1.00 per share (See Note 10).

Common Stock and Warrants

      In May 1997, the Company completed a private placement of stock and
received proceeds of $630,000 for 315,000 units, which consist of one share of
common stock and one warrant to purchase an additional share of common stock for
$3.00, expiring two years from the date of the closing. At any time following
the completion of an IPO of its securities, the Company may, under certain
circumstances, including, but not limited to, having an effective registration
statement covering the resale of the common stock underlying the warrants,
redeem the warrants at a price of $.01 per warrant on not less than 20 days
written notice if the last sale price of the common stock has averaged at least
$4.50 per share for the 20 consecutive trading days ending at least five days
prior to the date on which notice is given. of the amount raised, $75,000
represented payments from a Director of the Company for 37,500 units of the
Company's private placement.

      In May 1997, in connection with the private placement discussed above, the
Company issued warrants to the placement agent to purchase 7,500 units
consisting of one share of common stock for $2.25 per share, with an attached
warrant to purchase an additional share of common stock at $3.00 per share
expiring in June 2000. The placement agent is entitled to piggyback registration
rights with regards to the underlying common shares under the warrant agreement.
The Company allocated the net proceeds from the sale of the units to the common
stock and to the warrants issued.

      In November 1997, the Company completed an additional private placement of
stock and received proceeds of $1,117,000 for 558,500 units, consisting of one
share of the Company's common stock and one warrant to purchase an additional
share of common stock for $3.00, under the same terms as the warrants issued in
the May 1997 private placement. of this amount, $85,000 was received from
certain family members of existing shareholders of the Company for 42,500 units.

      In connection with the second private placement, the Company's Chief
Executive Officer converted indebtedness of $142,000 from the Company into a
subscription of 71,000 units.

      The Company recorded the proceeds from both private placements that
occurred during 1997, net of approximately $79,000 in issuance expenses.

      In 1998, the Company sold 258,000 shares of common stock at $2.00 per
share for total proceeds of $516,000. The Company completed two additional
private placements of common stock subsequent to December 31, 1998 (Note 9).

      In the opinion of management, all warrants have been issued with an
exercise price that is equal or above the fair market value of the Company's
Common Stock on the date of grant.

Stock Options

      In order to retain and attract qualified personnel necessary for the
success of the Company, the Company adopted a Stock Option Plan (the "1998 Stock
Option Plan") covering up to 400,000 of the Company's common shares, pursuant to
which officers, directors, key employees and consultants to the Company are
eligible to receive incentive stock options and nonqualified stock options. The
Compensation Committee of the Board of Directors administers the 1998 Stock
Option Plan and determines the terms and conditions of options granted,
including the exercise price. The 1998 Stock Option Plan provides that all stock
options will expire within ten years of the date of grant. Incentive stock
options granted under the 1998 Stock Option Plan must be granted at


                                      F-12
<PAGE>

an exercise price that is not less than the fair market value per share at the
date of grant and the exercise price must not be less than 110% of the fair
market value per share at the date of grant for grants to persons owning more
than 10% of the voting stock of the Company. The 1998 Stock Option Plan also
entitles nonemployee directors to receive grants of non-qualified stock options
as approved by the Board of Directors.

      Pursuant to the 1998 Stock Option Plan, the Company had granted in 1997,
50,000 stock options to each of three members of the Board of Directors, of
which all are exercisable at $3.00 per share and all expire within 5 years from
the date of grant. One of the directors had declined to stand for re-election to
the Board. In connection with this decision in 1999, the Company extended the
date of expiration of the former director's stock options until August 15, 2000.
The Company did not record a charge for the adjustment to the terms of the stock
options, as the amount was immaterial.

      In August 1999, the Company adopted the 1999 Stock Option Plan (Note 10).

      Had compensation for the 1998 and 1999 Stock Option Plans been determined
consistent with the provisions of SFAS No.123, the effect on the Company's net
loss and basic and diluted loss per share would have been changed to the
following pro forma amounts:

<TABLE>
<CAPTION>
                                                                                       Nine Months  Nine Months
                                                                                          Ended        Ended
                                                          Year Ended     Year Ended   September 30, September 30,
                                                         December 31,    December 31,     1998          1999
                                                             1997           1998       (unaudited)  (unaudited)
                                                         ------------   ------------  ------------  -----------
<S>                                                      <C>            <C>            <C>          <C>
Net loss, as reported ...............................    $(1,604,296)   $(1,503,814)   $(785,767)   $(1,249,458)
Net loss, pro forma .................................     (1,665,496)    (1,537,814)    (786,767)    (1,345,658)
Basic and diluted loss per share, as reported .......          (0.46)         (0.36)       (0.19)         (0.26)
Basic and diluted loss per share, pro forma .........          (0.48)         (0.37)       (0.19)         (0.29)
</TABLE>

      Stock option activity under the 1998 and 1999 Stock Option Plans during
the periods indicated is as follows:

                                                                     Weighted
                                                      Options         Average
                                                       Granted    Exercise Price
                                                      --------    --------------
Options outstanding at January 1, 1997 .............        --         $   --
  Granted ..........................................   180,000           3.00
  Canceled .........................................        --             --
                                                       -------       --------
Outstanding at December 31, 1997 ...................   180,000           3.00
  Granted ..........................................   100,000           3.00
  Canceled .........................................        --             --
                                                       -------       --------
Outstanding at December 31, 1998 ...................   280,000           3.00
  Granted ..........................................   430,000           3.23
  Canceled .........................................        --             --
                                                       -------       --------
Outstanding at September 30, 1999 (unaudited) ......   710,000       $   3.10
                                                       =======       ========

      The fair market value of each option grant has been estimated on the date
of grant using the Black-Scholes option pricing model based upon expected option
lives of 5 years; risk free interest rate of 5.00%; expected volatility of 0%
and a dividend yield of 0%.

      The weighted-average remaining life of the options outstanding at December
31, 1998 and September 30, 1999 is 3.82 years and 4.66 years (unaudited),
respectively, and the weighted-average fair value of the options outstanding at
December 31, 1998 and September 30, 1999 is $0.34 and $0.34 (unaudited),
respectively.

      On November 1, 1997, the Company entered into a one-year consulting
agreement with a member of the Board of Directors, who is not an employee, the
compensation for which was the issuance of options to


                                      F-13
<PAGE>

purchase 50,000 shares of Common Stock at $3.00 per share. The Company
determined the value of the options to be immaterial under the Black-Scholes
Option Pricing Model.

      In the opinion of management, all stock options have been issued with an
exercise price that is equal or above the fair market value of the Company's
Common Stock on the date of grant.

9. COMMITMENTS AND CONTINGENCIES

Operating Leases

      The Company has entered into various leases for office equipment and
office space expiring through October 2000. Future minimum lease payments under
these lease agreements are as follows:

      Year ending December 31:

            1999 ...............................................    $ 74,280
            2000 ...............................................      77,251
                                                                    --------
                                                                    $151,531
                                                                    ========
Capital Lease Obligations

      The Company leases computer equipment under several capital leases
expiring in 2000. The asset and liability are recorded at the lower of the
present value of minimum lease payments or the fair market value of the assets.

      Future minimum payments under the lease agreements are as follows:

      Year ending December 31:

            1999 .................................................    $ 8,941
            2000 .................................................      7,620
                                                                      -------
               Total minimum lease payments ......................     16,561
            Less -- Amount representing interest .................      1,560
                                                                      -------
               Present value of net minimum lease payments .......    $15,001
                                                                      =======
Royalty Agreements

      In January 1996, the Company entered into an agreement with a third party.
The agreement states that if the Company has sales exceeding $500,000 to certain
customers as specified within the agreement, the Company must pay between 2 to
4% of gross revenues as a royalty to the third party. In addition, if the
Company is sold to a prospective purchaser, as defined, the third party will
receive a fee ranging from 4 to 5% of the purchase price. The fee will be
determined based upon such purchase price. As each of the aforementioned events
had not occurred, no royalties were due as of December 31, 1998. The Company
settled this agreement subsequent to December 31, 1998 (Note 10).

      During 1997, the third party filed a lawsuit against the Company in the
New York State Supreme Court in Suffolk County, claiming that the Company had
breached the agreement entered into in January 1996 by failing to pay the third
party certain fees and/or royalties to which the third party believes he was
entitled in connection with sales of products of the Company to certain
designated parties.

      The Company stipulated with the third party the dismissal of the action
subsequent to December 31, 1998 (Note 10).

      The Company previously entered into an royalty agreement with the
President of the Company during 1996 to license certain software. The agreement
stipulated, among other provisions, that the President would receive royalties
equal to a percentage of the Company's gross sales. As of December 31, 1998, no
amounts have been earned under this agreement. This agreement was terminated in
May 1999 and superceded by a new agreement. (Note 10).

Employment Agreement

      On July 1, 1996, the Company entered into a one-year employment contract
with its Chairman and Chief Executive Officer. Each party has agreed to defer
the payment until such time as the Company has significant


                                      F-14
<PAGE>

sales of its product. Under the terms of the agreement, the Company had extended
the employment agreement one-month for each month of salary not paid. As of
December 31, 1998, no amounts had been paid to the Chairman and Chief Executive
Officer. The agreement was replaced with a new employment agreement in January
1999 (Note 10).

Supplier Agreement

      In December 1996, the Company signed an exclusive supplier agreement with
Hazeltine Corporation ("Hazeltine"). The agreement specifies that the Company
would make total payments of $499,563 for the design and production of one
hundred pre-production prototypes. In addition, Hazeltine agreed to manufacture
ID-Check products, for a price determined by the terms of the agreement, for an
initial term of five years from the end of the calendar year in which
Hazeltine's sales of ID-Check products to the Company first achieve a rate of
not less than 100,000 units per year. The Company terminated said agreement
subsequent to December 31, 1998 (Note 10).

10. SUBSEQUENT EVENTS

Employment Agreements

      On January 1, 1999, the Company entered into three-year employment
contracts with both its Chairman and Chief Executive Officer and its President.
Each of the agreements provides for a base salary of $225,000 and the payment of
a bonus if the Company's sales exceed $2,000,000 in the previous year. The bonus
will be in the amount of $50,000 plus 1% of the amount of sales in excess of
$2,000,000 in each year. In addition, for each fiscal year ending during the
term of the employment agreements, the Company will grant to each of the
executives an option to purchase the greater of 25,000 shares of our common
stock at fair market value on the date of grant or 10,000 shares of our common
stock at fair market value on the date of grant for each full $250,000 by which
pre-tax profits for each year exceeds pre-tax profits for the prior fiscal year.
However, the Company is not required to grant options to purchase more than
150,000 shares of our common stock with respect to any one fiscal year.

      In July 1999, the Company entered into a two-year employment agreement
with its new Chief Financial Officer, which became effective on September 7,
1999. The agreement provides for a base salary of $125,000. In addition, the
Company granted the Chief Financial Officer an option to purchase 50,000 shares
of common stock, of which 10,000 options are immediately exercisable at $5.00
per share, 20,000 options are exercisable on September 7, 2000 at the initial
public offering price and 20,000 options become exercisable at the initial
public offering price when all external accounting functions, except for
year-end audit, are being performed internally.

Private Placements of Common Stock

      In January 1999, the Company completed a private placement of stock, which
originally commenced in 1998. During January 1999, the Company sold 15,000
units, consisting of one share of the Company's common stock and one warrant to
purchase an additional share of common stock at $3.00, expiring two years from
the date of closing. The Company received total proceeds of $30,000 in January
1999. The Company allocated the net proceeds from the sale of the units to the
common stock and to the warrant.

      In March 1999, the Company commenced an additional private placement and
sold 259,600 units, consisting of one share of common stock and one warrant to
purchase an additional share of common stock at $3.00, expiring two years from
the date of closing. The Company received total proceeds of $489,200 prior to
June 30, 1999 and the remaining balance of $30,000 in August 1999. The Company
allocated the net proceeds from the sale of the units to the common stock and to
the warrant.

      In the opinion of management, all of the above warrants have been issued
with an exercise price that is equal or above the fair market value of the
Company's Common Stock on the date of grant.

Warrants

      In February 1999, the Company extended the expiration dates for the
warrants issued on May 26, 1997 and November 30, 1997 until June 30, 2000. The
Company did not record a charge for the adjustment to the terms of the warrants,
as the amount was immaterial.


                                      F-15
<PAGE>

      In March 1999, the Company issued warrants to GunnAllen Financial, Inc. to
purchase 50,000 shares of common stock at an exercise price of $3.00 per share
expiring March 24, 2002. The warrants were issued in connection with a
consulting service agreement and in the opinion of management have been issued
with an exercise price that is equal or above the fair market value of the
Company's Common Stock on the date of grant. The Company did not record a charge
for the issuance to the terms of the warrants, as the amount was immaterial. In
the opinion of management, the exercise price of the warrant was equal or above
the fair market value of the Company's Common Stock on the date of the grant.

      In April 1999, the Company adjusted the exercise price of a warrant to
purchase common stock of the Company issued to the Foundation, in a previous
common stock private placement, from $3.00 to $2.00. The adjustment was
contingent upon the Foundation exercising the warrants within thirty days of the
adjustment. The Company did not record a charge for the adjustment to the terms
of the warrants, as the amount was immaterial as the exercise price of the
warrant was equal or above the fair market value of the Company's Common Stock
on the date of the adjustment. The Foundation exercised this warrant in May 1999
at the adjusted exercise price and the Company received total proceeds of
$200,000. In addition, the Foundation received a new warrant to purchase 100,000
shares of the Company's common stock at an exercise price of $3.00 per share
expiring in May 2001. In the opinion of management, the new warrant has been
issued with an exercise price that is equal or above the fair market value of
the Company's Common Stock on the date of grant.

Repayment of Note Payable

      In connection with an agreement executed in May 1999, which superceded a
prior license agreement, the Company repaid an outstanding loan of $98,151 and
accrued interest of $41,724 to the President of the Company. The Company paid
$1.00 in cash and issued 69,937 units, consisting of one share of the Company's
common stock and one warrant to purchase an additional share of common stock at
$3.00, expiring in May 2001. The units were valued at $2.00 per unit, with the
value primarily allocated to the share of common stock. In addition, under the
agreement, the Company is licensing certain software from the President and has
agreed to pay the executive royalties equal to .005% on gross sales from
$2,000,000 to $52,000,000 and .0025% on gross sales in excess of $52,000,000.

Conversion of Deferred Salary

      In May 1999, the Chairman and Chief Executive Officer converted $150,000
in deferred salary into 75,000 units, consisting of one share of the Company's
common stock and one warrant to purchase an additional share of common stock at
$3.00, expiring in May 2001. In addition, the Company's President converted
$10,126 in deferred salary into 5,063 units, consisting of one share of the
Company's common stock and one warrant to purchase an additional share of common
stock at $3.00, expiring in May 2001.

      In June 1999, the Chairman and Chief Executive officer converted
approximately $380,000 in deferred salary and interest into 375,000 options to
purchase a share of common stock at $3.00, expiring in June 2004. In addition,
the Company's President converted approximately $210,000 in deferred salary and
interest into 207,000 options to purchase a share of common stock at $3.00,
expiring in June 2004. Furthermore, the Company's former President converted
approximately $110,000 in deferred salary and interest into 110,000 options to
purchase a share of common stock at $3.00, expiring in June 2004.

Settlement Agreements

      In connection with an outstanding lawsuit, the Company stipulated with the
plaintiff to the dismissal of the action, which had been pending since January
1997 in the New York State Supreme Court, Suffolk County, on February 22, 1999.
In exchange for the plaintiff's dismissal of his claims against the Company and
execution of a release of all claims against the Company, the Company has agreed
to dismiss its counterclaim against the plaintiff and execute a reciprocal
release for him. The settlement does not provide for any repayment from the
Company to the plaintiff or from the plaintiff to the Company.

      In May 1999, the Company and the third party agreed to terminate the
royalty agreement pursuant to a Settlement Agreement. Under the Settlement
Agreement, the Company issued 10,000 shares of common stock, valued at $2.00 per
share with piggyback registration rights, to the third party in exchange for the
termination of


                                      F-16
<PAGE>

the royalty agreement. The Company recorded a charge of $20,000 in the
accompanying statement of operations for the six months ended June 30, 1999
(unaudited). The Company has no further liability to the third party.

      In June 1999, the Company and Hazeltine (succeeded by Marconi Aerospace
Systems, Inc.) entered into an agreement to terminate the Exclusive Supplier
Agreement. Under the terms of the termination agreement, Hazeltine will return
all units of the Company's ID-Check in its possession as well as all samples,
designs, drawings, software, molds and any other item related to the ID-Check.
The Company issued 75,000 shares of common stock to Hazeltine in order to
satisfy outstanding payables of approximately $220,000 due Hazeltine, which was
included in accounts payable in the accompanying December 31, 1998 balance
sheet.

Common Stock Issued for Services

      In June 1999, the Company issued 9,000 shares of common stock to a third
party for professional services rendered on behalf of the Company. The shares
were valued at $4.00 per share, and accordingly, the Company recorded a charge
of $36,000 in the accompanying statement of operations for the nine months ended
September 30, 1999 (unaudited).

Supplier Agreement

      In June 1999, the Company entered into a new supplier agreement with Welch
Allyn, Inc., and the Company immediately executed its first order with Welch
Allyn, Inc., for the purchase of 525 units of its newly designed product.

Conversion of Preferred Stock

      In July 1999, the Foundation converted 250,000 shares of Series A
Convertible Preferred Stock into 250,000 shares of common stock.

Secured Promissory Notes

      In August and September 1999, the Company placed $1,200,000 of secured
promissory notes with interest at 10% for net proceeds of $1,050,000. The notes
have warrants attached to purchase 2,500 shares of common stock for each
principal amount of $50,000, at $3.00 per share. The warrants expire in August
2002 and can be redeemed by the Company at $.01 per warrant at any time the
Company's common stock has an average market price of $6.00 per share for a
period of twenty consecutive trading days. The fair value of the warrants was
deemed to be immaterial. The notes mature at the earlier of July 31, 2000 or the
date at which the Company receives gross proceeds from a public offering of its
securities of at least $6,000,000.

1999 Stock Option Plan

      In August 1999, the Company adopted the 1999 Stock Option Plan (the "1999
Stock Option Plan") covering up to 1,000,000 of the Company's common shares,
pursuant to which officers, directors, key employees and consultants to the
Company are eligible to receive incentive stock options and nonqualified stock
options. The Compensation Committee of the Board of Directors administers the
1999 Stock Option Plan and determines the terms and conditions of options
granted, including the exercise price. The 1999 Stock Option Plan provides that
all stock options will expire within ten years of the date of grant. Incentive
stock options granted under the 1999 Stock Option Plan must be granted at an
exercise price that is not less than the fair market value per share at the date
of grant and the exercise price must not be less than 110% of the fair market
value per share at the date of grant for grants to persons owning more than 10%
of the voting stock of the Company. The 1999 Stock Option Plan also entitles
nonemployee directors to receive grants of non-qualified stock options as
approved by the Board of Directors.

Initial Public Offering

      The Company has entered into a letter of intent for an initial public
offering of its common stock. The offering contemplates the sale of 1,000,000
shares of common stock at an offering price of $7.00 per share before
underwriting commissions and offering expenses.


                                      F-17
<PAGE>

================================================================================

      We have not authorized any dealer, salesperson or any other person to give
any information or to represent anything not contained in this prospectus. You
must not rely on any unauthorized information. This prospectus does not offer to
sell or buy any shares in any jurisdiction where it is unlawful.

                                   ----------

                                TABLE OF CONTENTS

                                                                            Page
                                                                            ----

Prospectus Summary .......................................................     3
Risk Factors .............................................................     5
Forward-Looking Statements ...............................................     6
Use of Proceeds ..........................................................     7
Dilution .................................................................     8
Dividends ................................................................     8
Capitalization ...........................................................     9
Management's Discussion and Analysis
  of Financial Condition and
  Results of Operations ..................................................    10
Business .................................................................    14
Management ...............................................................    23
Principal and Selling Stockholders .......................................    29
Certain Transactions .....................................................    30
Description of Securities ................................................    31
Shares Eligible for Future Sale ..........................................    32
Underwriting .............................................................    33
Legal Matters ............................................................    35
Experts ..................................................................    35
Additional Information ...................................................    35
Index to the Company's
  Financial Statements ...................................................   F-1


                                   ----------

      Until , 1999, all dealers effecting transactions in the registered
securities, whether or not participating in this offering, may be required to
deliver a prospectus. This is in addition to the dealers' obligation to deliver
a prospectus when acting as underwriters and with respect to their unsold
allotments or subscriptions.

================================================================================



================================================================================

                                1,000,000 SHARES


                          [LOGO] INTELLI-CHECK(R), INC.


                                  Common Stock


                                   ----------

                                   Prospectus

                                   ----------


                                    GunnAllen
                                    Financial


                              Starr Securities,Inc.
                                     [LOGO]


                                              , 1999

================================================================================

<PAGE>


                                    PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS

      Intelli-Check's Certificate of Incorporation limits the liability of
directors to the maximum extent permitted by Delaware General Corporation Law.
Delaware law provides that the directors of a corporation will not be personally
liable to such corporation or its stockholders for monetary damages for breach
of their fiduciary duties as directors, except for liability (i) for any breach
of their duty of loyalty to the corporation or its stockholders; (ii) for acts
or omissions not in good faith or which involve intentional misconduct or a
knowing violation of law; (iii) for unlawful payments of dividends or unlawful
stock repurchases or redemptions as provided in Section 174 of the Delaware
General Corporation Law; or (iv) for any transaction from which the director
derives an improper personal benefit. Intelli-Check's By-laws provide that the
Company shall indemnify its directors and officers under certain circumstances,
including those circumstances in which indemnification would otherwise be
discretionary, and the Company is required to advance expenses to its officers
and directors as incurred in connection with proceedings against them for which
they may be indemnified.

ITEM 25. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION

      The following table sets forth the costs and expenses, other than the
underwriting discount and the underwriters' non-accountable expense allowance,
payable by the Registrant in connection with the sale of common stock being
registered. All amounts are estimates except the SEC registration fee and the
American Stock Exchange filing fees.

                                                                        Amount
                                                                      ---------
     SEC registration fee........................................     $  2,500
     NASD filing fee.............................................        1,500
     American Stock Exchange listing fee.........................       42,500
     Blue sky fees and expenses (including legal fees)...........       10,000
     Transfer agent fees.........................................        5,000
     Printing....................................................       75,000
     Legal fees and expenses.....................................      150,000
     Accounting fees and expenses................................      100,000
     Miscellaneous...............................................       50,000
                                                                       --------
          Total                                                       $436,500
                                                                      ========

ITEM 26. RECENT SALES OF UNREGISTERED SECURITIES


      In the past three years, the Company made the following sales of
unregistered securities pursuant to exemptions from the registration
requirements of the Securities Act of 1933, as amended (the Securities Act). In
each case, the Company made an independent determination that the investor was
"sophisticated", within the meaning of the securities laws, and the Company
believes that each of these investors had, or was likely to have had, access to
information about the Company as would ordinarily be disclosed in a registration
statement.


      In September 1996, we sold a total of 87,500 shares of our common stock
for $175,000. Paul Cohen and Eric Cohen, the father and brother of our
co-founder, Todd Cohen, purchased 62,500 shares and 15,000 shares, respectively.
Gregg Messina, the brother of our co-founder, Kevin Messina, purchased 10,000
shares. In connection with the issuance, (i) each shareholder represented to the
Company that, by virtue of his investment acumen, business experience or
independent financial and tax advice, he had the capability of evaluating the
risks and merits in investing in the shares, (ii) each shareholder represented
that the shares acquired cannot be sold without registration under the
Securities Act, except in reliance upon an exemption therefrom and (iii) the
Company did not engage in any general solicitation or advertisement for the
issuance. The shareholders further represented their intention to acquire the
securities for investment only and not with a view to the distribution


                                       II-1
<PAGE>


thereof. Appropriate legends were affixed to the stock certificates issued in
such transactions. Each shareholder had adequate access to sufficient
information about the Company to make an informed investment decision.

The issuance and sale of these securities were made in reliance on the exemption
provided by Section 4(2) of the Securities Act, as a transaction not involving
any public offering.

      In October 1996, we issued a total of 41,385 shares of our common stock to
satisfy loans in the aggregate amount of $82,770. Paul Cohen, the father of our
co-founder, Todd Cohen, accepted 28,885 shares in repayment of $57,770 of
indebtedness and William Glasgow, who has been, since September 1996, director
of corporate accounts of the Company, accepted 12,500 shares in repayment of
$25,000 of indebtedness. Also in October 1996, we issued a total of 22,500
shares of our common stock in repayment of $45,000 owed to our former attorneys,
Post & Heymann LLP. In connection with the issuance, (i) each shareholder
represented to the Company that, by virtue of his investment acumen, business
experience or independent financial and tax advice, he had the capability of
evaluating the risks and merits in investing in the shares, (ii) each
shareholder represented that the shares acquired cannot be sold without
registration under the Securities Act, except in reliance upon an exemption
therefrom and (iii) the registrant did not engage in any general solicitation or
advertisement for the issuance. The shareholders further represented their
intention to acquire the securities for investment only and not with a view to
the distribution thereof. Appropriate legends were affixed to the stock
certificates issued in such transactions. Each shareholder had adequate access
to sufficient information about the Company to make an informed investment
decision. The issuance and sale of these securities were made in reliance on the
exemption provided by Section 4(2) of the Securities Act, as a transaction not
involving any public offering.

      In December 1996 and January 1997, Frank Mandelbaum, our chief executive
officer, made loans totalling $142,000 with interest at 10% with maturity in 90
days. He subsequently extended the notes on several occasions. In November 1997,
as part of the private placement discussed below, we issued to Mr. Mandelbaum
71,000 shares of our common stock and warrants to purchase 71,000 shares of our
common stock at an exercise price of $3.00 per share in exchange for Mr.
Mandelbaum's forgiveness of his loan to us of $142,000. Mr. Mandelbaum is an
accredited investor, as that term is defined in Regulation D promulgated under
the Securities Act. The securities issued to Mr. Mandelbaum contain a legend
stating that the securities acquired cannot be sold without registration under
the Securities Act, except in reliance upon an exemption therefrom. As the chief
executive officer, Mr. Mandelbaum had adequate access to sufficient information
about the Company to make an informed investment decision. The Company did not
engage in any general solicitation or advertisement for the issuance. The
issuance and sale of these securities were made in reliance on the exemption
provided by Section 4(2) of the Securities Act, as a transaction not involving
any public offering.

      In January 1997, we entered into a Note Purchase Agreement with the New
York State Science and Technology Foundation pursuant to which we issued a
Convertible Promissory Note in the amount of $250,000. The Foundation also
agreed to invest an additional $250,000 through the purchase of 125,000 shares
of Series A convertible preferred stock based upon our raising a certain amount
of additional capital. The note bore interest at 8% per annum. In January 1998,
we exercised our right to redeem the convertible promissory note held by the
Foundation for 125,000 shares of Series A convertible preferred stock. In
addition, the Foundation purchased an additional 125,000 shares of Series A
convertible preferred stock for $250,000. In July 1999, the Foundation exercised
its conversion rights and received 250,000 shares of common stock in exchange
for its preferred stock. The New York State Science and Technology Foundation
subscribed to 100,000 units for $200,000 in the private placement of September
1998, discussed below, which units consisted of one share of common stock and
one warrant to acquire an additional share at $3.00 per share. In April 1999, we
adjusted the exercise price of warrants issued to the Foundation from $3.00 to
$2.00 if exercised within 30 days of the adjustment. In May 1999, the Foundation
exercised such warrant and we issued 100,000 shares of our common stock and a
new warrant to purchase 100,000 shares of our common stock at an exercise price
of $3.00, which expires in May 2001. In connection with the issuance of
securities to the New York State Science and Technology Foundation, (i) the
Foundation represented to the Company that it and/or its officers or employees
were experienced in evaluating and investing in newly-organized, high-technology
companies such as the Company, (ii) the Foundation represented that the shares
acquired cannot be sold without registration under the Securities Act, except in
reliance upon an exemption therefrom and (iii) the Company did not engage in any
general solicitation or advertisement for the issuance. Appropriate legends were
affixed to the stock certificates


                                      II-2
<PAGE>


issued in such transactions. The Foundation had adequate access to sufficient
information about the Company to make an informed investment decision. The
issuance and sale of these securities were made in reliance on the exemption
provided by Section 4(2) of the Securities Act, as a transaction not involving
any public offering.

      In February 1997, we issued 12,000 shares of our common stock to
Blanchfield King Kober, our former accountants, in payment of accounting fees
totaling $24,000. In June 1999, we issued an additional 9,000 shares of our
common stock to Blanchfield King Kober in payment of accounting fees totalling
$36,000. The Company believes that these accountants have such knowledge and
experience in financial and business matters that they were capable of
evaluating the merits and risks of the investment. The shares issued to the
shareholders contain a legend stating that the shares acquired cannot be sold
without registration under the Securities Act, except in reliance upon an
exemption therefrom. Because of their relationship with the Company, the
shareholders had adequate access to sufficient information about the Company to
make an informed investment decision. The Company did not engage in any general
solicitation or advertisement for the issuance. The issuance and sale of these
securities were made in reliance on the exemption provided by Section 4(2) of
the Securities Act, as a transaction not involving any public offering.

      In May 1997 and June 1997, we sold 315,000 units to 8 purchasers, which
units consisted of one share of common stock and one warrant to acquire an
additional share at $3.00 per share originally set to expire in June 1999 in a
private placement with respect to which Jesup & Lamont Securities Corp. acted as
placement agent. The placement agent received a commission of $45,500 and a
non-accountable expense allowance of $20,000 in connection with the private
placement. Net proceeds to us were $550,849. Of the amount raised, $75,000
represented payment from one of our directors for 37,500 units. Our company also
issued to the placement agent non-redeemable warrants to purchase 7,500 units
for $2.25 per unit, which includes one share of common stock and an attached
warrant to purchase an additional share of common stock at $3.00 per share. In
connection with the issuance, (i) each shareholder represented to the Company
that he was either an accredited investor, as that term is defined in Regulation
D promulgated under the Securities Act, and/or that he and such other persons as
he found it necessary or advisable to consult, have sufficient knowledge and
experience in business and financial matters to evaluate the risks of the
investment and to make an informed investment decision with respect thereto,
(ii) each shareholder represented that the securities acquired cannot be sold
without registration under the Securities Act, except in reliance upon an
exemption therefrom and (iii) the Company did not engage in any general
solicitation or advertisement for the issuance. The shareholders further
represented their intention to acquire the securities for investment only and
not with a view to the distribution thereof. Appropriate legends were affixed to
the stock certificates and warrants issued in such transactions. Each
shareholder had adequate access to sufficient information about the Company to
make an informed investment decision. The issuance and sale of these securities
were made in reliance on the exemption provided by Section 4(2) of the
Securities Act, as a transaction not involving any public offering.

      In November 1997, we sold in a private placement a total of 558,500 units
to 15 purchasers, which units consisted of one share of common stock and one
warrant to acquire an additional share at $3.00 per share originally set to
expire in November 1999. Our company received net proceeds of $1,117,000 from
this offering. In connection with the issuance, (i) each shareholder represented
to the Company that he was either an accredited investor, as that term is
defined in Regulation D promulgated under the Securities Act, and/or that he and
such other persons as he found it necessary or advisable to consult, have
sufficient knowledge and experience in business and financial matters to
evaluate the risks of the investment and to make an informed investment decision
with respect thereto, (ii) each shareholder represented that the securities
acquired cannot be sold without registration under the Securities Act, except in
reliance upon an exemption therefrom and (iii) the Company did not engage in any
general solicitation or advertisement for the issuance. The shareholders further
represented their intention to acquire the securities for investment only and
not with a view to the distribution thereof. Appropriate legends were affixed to
the stock certificates and warrants issued in such transactions. Each
shareholder had adequate access to sufficient information about the Company to
make an informed investment decision. The issuance and sale of these securities
were made in reliance on the exemption provided by Section 4(2) of the
Securities Act, as a transaction not involving any public offering.

      In July 1998, we commenced a private placement of 500,000 units at $6.00
per unit. These units consisted of two shares of common stock at $3.00 per share
and one warrant to acquire an additional share at $5.00 per share expiring two
years from the date of the closing. In connection with this offering, the
Company sold



                                      II-3
<PAGE>


31,000 units and received proceeds of $186,000. Due to market conditions
prevailing at that time for raising capital, we rescinded the offering and all
the subscribers agreed to re-subscribe under the terms of the September 1998
offering.

      In September 1998, we commenced a private placement of 1,000,000 units at
$2.00 per unit. These units consisted of one share of common stock and one
warrant to acquire an additional share at $3.00 per share. The offering was
extended to January 17, 1999. We sold 273,000 units to 4 purchasers and received
$546,000 as a result of the offering, of which $30,000 was received in January
1999. In connection with the issuance, (i) each shareholder represented to the
Company that he was either an accredited investor, as that term is defined in
Regulation D promulgated under the Securities Act, and/or that he and such other
persons as he found it necessary or advisable to consult, have sufficient
knowledge and experience in business and financial matters to evaluate the risks
of the investment and to make an informed investment decision with respect
thereto, (ii) each shareholder represented that the securities acquired cannot
be sold without registration under the Securities Act, except in reliance upon
an exemption therefrom and (iii) the Company did not engage in any general
solicitation or advertisement for the issuance. The shareholders further
represented their intention to acquire the securities for investment only and
not with a view to the distribution thereof. Appropriate legends were affixed to
the stock certificates and warrants issued in such transactions. Each
shareholder had adequate access to sufficient information about the Company to
make an informed investment decision. The issuance and sale of these securities
were made in reliance on the exemption provided by Section 4(2) of the
Securities Act, as a transaction not involving any public offering.

      In February 1999, we extended the expiration date for the warrants issued
in May 1997, June 1997 and November 1997 until June 30, 2000.

      In March 1999, we commenced a private placement and sold 259,600 units to
17 purchasers at $2.00 per unit. These units consisted of one share of common
stock and one warrant to acquire an additional share at $3.00 per share. We
received $489,200 as a result of the offering prior to June 30, 1999 and $30,000
in August, 1999. In connection with the issuance, (i) each shareholder
represented to the Company that he was either an accredited investor, as that
term is defined in Regulation D promulgated under the Securities Act, and/or
that he and such other persons as he found it necessary or advisable to consult,
have sufficient knowledge and experience in business and financial matters to
evaluate the risks of the investment and to make an informed investment decision
with respect thereto, (ii) each shareholder represented that the securities
acquired cannot be sold without registration under the Securities Act, except in
reliance upon an exemption therefrom and (iii) the Company did not engage in any
general solicitation or advertisement for the issuance. The shareholders further
represented their intention to acquire the securities for investment only and
not with a view to the distribution thereof. Appropriate legends were affixed to
the stock certificates and warrants issued in such transactions. Each
shareholder had adequate access to sufficient information about the Company to
make an informed investment decision. The issuance and sale of these securities
were made in reliance on the exemption provided by Section 4(2) of the
Securities Act, as a transaction not involving any public offering.

      In March 1999, we issued warrants to GunnAllen Financial, Inc. to purchase
50,000 shares of our common stock at an exercise price of $3.00 per share
expiring March 24, 2002. These warrants were issued in payment of the fee under
a consulting agreement. The Company believes that this broker dealer had such
knowledge and experience in financial and business matters that it was capable
of evaluating the merits and risks of the investment. The Company did not engage
in any general solicitation or advertisement for the issuance. GunnAllen had
adequate access to sufficient information about the Company to make an informed
investment decision. The issuance and sale of these securities were made in
reliance on the exemption provided by Section 4(2) of the Securities Act, as a
transaction not involving any public offering.

      In May 1999, we issued 10,000 shares of our common stock to Allan Binder
in exchange for the termination of a royalty agreement. Mr. Binder is an
attorney and served as a consultant to the Company. Because of his relationship
with the Company, Mr. Binder had adequate access to sufficient information about
the Company to make an informed investment decision. The Company believes that
Mr. Binder had such knowledge and experience in financial and business matters
that he was capable of evaluating the merits and risks of the investment. The
shares issued to Mr. Binder contain a legend stating that the shares acquired
cannot be sold without registration under the Securities Act, except in reliance
upon an exemption therefrom. The


                                      II-4
<PAGE>


Company did not engage in any general solicitation or advertisement for the
issuance. The issuance and sale of these securities were made in reliance on the
exemption provided by Section 4(2) of the Securities Act, as a transaction not
involving any public offering.

      In May 1999, we issued to Frank Mandelbaum, our chief executive officer,
75,000 shares of our common stock and warrants to purchase 75,000 shares at an
exercise price of $3.00 per share and we issued to Kevin Messina, our president,
5,063 shares of our common stock and warrants to purchase 5,063 shares at an
exercise price of $3.00 per share. These issuances reduced Mr. Mandelbaum's
deferred compensation by $150,000 and Mr. Messina's deferred compensation by
$10,126. In addition, we issued to Mr. Messina 69,937 shares of our common stock
and warrants to purchase 69,937 shares of our common stock at an exercise price
of $3.00 per share in exchange for the termination of Mr. Messina's reversion
rights for certain software. In June 1999, all remaining deferred compensation
and interest due to Mr. Mandelbaum, Mr. Messina and Todd Cohen, our co-founder,
was eliminated by the issuance of options to purchase 375,000, 207,000 and
110,000 shares of our common stock. Mr. Mandelbaum's deferred compensation was
reduced by approximately $380,000, Mr. Messina's deferred compensation was
reduced by approximately $210,000 and Mr. Cohen's deferred compensation was
reduced by approximately $110,000. Mr. Mandelbaum is an accredited investor, as
that term is defined in Regulation D promulgated under the Securities Act. In
addition, the Company believes that each of these members of senior management
had such knowledge and experience in financial and business matters that they
were capable of evaluating the merits and risks of the investment. The
securities issued to the shareholders contain a legend stating that the
warrants, options and underlying shares cannot be sold without registration
under the Securities Act, except in reliance upon an exemption therefrom. As
members of senior management, Messrs. Mandelbaum, Messina and Cohen had adequate
access to sufficient information about the Company to make an informed
investment decision. The Company did not engage in any general solicitation or
advertisement for the issuance. The issuance and sale of these securities were
made in reliance on the exemption provided by Section 4(2) of the Securities
Act, as a transaction not involving any public offering.

      In June 1999, we agreed to terminate the supplier agreement we had with
Marconi Aerospace Systems, Inc., formerly Hazeltine, for which we issued 75,000
shares of our common stock to Marconi in payment of outstanding invoices
totalling $220,000, and we received all units of ID-Check which had been
manufactured, all samples, designs, drawings, software, molds and any other item
related to ID-Check. In connection with the issuance, (i) the shareholder
represented to the Company that it was an accredited investor, as that term is
defined in Regulation D promulgated under the Securities Act, and that it had
sufficient knowledge and experience in business and financial matters to
evaluate the risks of the investment and to make an informed investment decision
with respect thereto, (ii) the shareholder represented that the securities
acquired cannot be sold without registration under the Securities Act, except in
reliance upon an exemption therefrom and (iii) the Company did not engage in any
general solicitation or advertisement for the issuance. The shareholder further
represented its intention to acquire the securities for investment only and not
with a view to the distribution thereof. Appropriate legends were affixed to the
stock certificates issued in such transaction. The shareholder had adequate
access to sufficient information about the Company to make an informed
investment decision. The issuance and sale of these securities were made in
reliance on the exemption provided by Section 4(2) of the Securities Act, as a
transaction not involving any public offering.

      In August and September 1999 we sold to 27 investors $1,200,000 of secured
promissory notes with interest at 10%. These notes have warrants attached to
purchase 2,500 shares for each principal amount of $50,000 at $3.00 per share,
which expire in August 2002 and can be redeemed by us at $.01 per warrant at any
time that our stock has a public market price of $6.00 per share for 20
consecutive days. The notes mature on the sooner of July 31, 2000 or the date
that we receive gross proceeds from a public offering of our securities of
$6,000,000. In connection with the issuance, (i) each noteholder represented to
the Company that he was either an accredited investor, as that term is defined
in Regulation D promulgated under the Securities Act, and/or that he and such
other persons as he found it necessary or advisable to consult, have sufficient
knowledge and experience in business and financial matters to evaluate the risks
of the investment and to make an informed investment decision with respect
thereto, (ii) each noteholder represented that the notes, warrants and
underlying shares cannot be sold without registration under the Securities Act,
except in reliance upon an exemption therefrom and (iii) the Company did not
engage in any general solicitation or advertisement for the issuance. The
noteholders further represented their intention to acquire the securities for
investment only and not with a


                                       II-5
<PAGE>


view to the distribution thereof. Appropriate legends were affixed to the notes
and warrants issued in such transactions. Each noteholder had adequate access to
sufficient information about the Company to make an informed investment
decision. The issuance and sale of these securities were made in reliance on the
exemption provided by Section 4(2) of the Securities Act, as a transaction not
involving any public offering.

ITEM 27. EXHIBITS

Number      Description
- -------     ----------
   1        Form of Underwriting Agreement*

   3.1      Certificate of Incorporation of the Company*

   3.2      By-laws of the Company*


   4.1      Specimen Stock Certificate*


   4.2      Form of Underwriters' Warrant Agreement*


   5        Opinion of Milberg Weiss Bershad Hynes & Lerach LLP*


  10.1      1998 Stock Option Plan*

  10.2      Employment Agreement between Frank Mandelbaum and the Company, dated
            as of January 1, 1999*

  10.3      Employment Agreement between Kevin Messina and the Company, dated as
            of January 1, 1999*

  10.4      Employment Agreement between Edwin Winiarz and the Company, dated as
            of July 21,  1999*

  10.5      Agreement of Lease between the Company and The Huntington  Atrium,
            dated as of October 25, 1996*

  10.6      1999 Stock Option Plan* 10.7 Development and Supply Agreement
            between the Company and Welch Allyn Data Collection Inc., dated July
            9, 1999**

  10.8      Agreement between the Company and Northern Leasing Systems Inc.,
            dated as of August 13, 1999*


  10.9      Employment Agreement between the Company and W. Robert Holloway,
            dated October 25, 1999*

  10.10     Agreement between the Company and Kevin Messina, individually and
            d/b/a K.M. Software Development, dated as of May 3, 1999*


  10.11     Memorandum of Understanding between AAMVAnet, Inc. and
            Intelli-Check, Inc. effective November 15, 1999.***



  21        List of Subsidiaries*

  23(1)     Consent of Milberg Weiss Bershad Hynes & Lerach LLP (included in
            Exhibit 5)

  23(2)     Consent of Arthur Andersen LLP***

  24        Power of Attorney*


  27        Financial Data Schedule*


- ----------
  *  Previously filed.
 **  Previously filed in redacted form pursuant to Rule 406 under the Securities
     Act. Previously filed separately in unredacted form subject to a request
     for confidential treatment under Rule 406.
***  Filed herewith.

ITEM 28. UNDERTAKINGS

      Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors, officers and controlling persons of
the Registrant pursuant to the foregoing provisions, or otherwise, the
Registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act
and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.


                                      II-6
<PAGE>



      The undersigned Registrant hereby undertakes:

      (1)   That it will file, during any period in which in offers or sells
            securities, a post-effective amendment to this registration
            statement to:

            (i)   Include any prospectus required by section 10(a)(3) of the
                  Securities Act;

            (ii)  Reflect in the prospectus any facts or events which,
                  individually or together, represent a fundamental change in
                  the information in the registration statement; and

            (iii) Include any additional or changed material information on the
                  plan of distribution.

      (2)   That for determining liability under the Securities Act, it will
            treat each post-effective amendment as a new registration statement
            of the securities offered, and the offering of the securities at
            that time to be the initial bona fide offer.

      (3)   To file a post-effective amendment to remove from registration any
            of the securities that remain unsold at the end of the Offering.

      (4)   To provide to the underwriters at the closing specified in the
            Underwriting Agreement certificates in such denomination and
            registered in such names as required by the underwriters to permit
            prompt delivery to each purchaser.

      (5)   For purposes of determining any liability under the Securities Act
            of 1933, the information omitted from the form of prospectus filed
            as part of this registration statement in reliance upon Rule 430A
            and contained in a form of prospectus filed by the registrant
            pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act
            shall be deemed to be part of this registration statement as of the
            time it was declared effective.

      (6)   For the purpose of determining any liability under the Securities
            Act of 1933, each post-effective amendment that contains a form of
            prospectus shall be deemed to be a  new registration statement
            relating to the securities offered therein, and the offering of such
            securities at that time shall be deemed to be the initial bona fide
            offering thereof.

                                      II-7

<PAGE>


                                   SIGNATURES


      In accordance with the requirements of the Securities Act of 1933, the
registrant has duly caused this Amendment No. 2 to the Registration Statement to
be signed on its behalf by the undersigned, thereunto duly authorized, in the
City of New York, State of New York, on November 15, 1999.


                                   INTELLI-CHECK, INC.

                                   By  /S/ FRANK MANDELBAUM

                                       ---------------------------------------
                                       Frank Mandelbaum, Chairman
                                       and Chief Executive Officer


      Pursuant to the requirements of the Securities Act of 1933, as amended,
this Amendment No. 2 to the Registration Statement has been signed by the
following persons in the capacities indicated below:

Dated: November 15, 1999                /S/ FRANK MANDELBAUM
                                        ---------------------------------------

                                        Frank Mandelbaum, Chairman, Chief
                                        Executive Officer and Director


Dated: November 15, 1999                /S/ *
                                        ---------------------------------------
                                        Kevin Messina, President, Chief
                                        Technology Officer and Director

Dated: November 15, 1999                /S/ *
                                        ---------------------------------------
                                        Edwin Winiarz, Executive Vice President,
                                        Treasurer, Chief Financial Officer and
                                        Director

Dated: November 15, 1999                *
                                        ---------------------------------------
                                        Paul Cohen, Director

Dated: November 15, 1999
                                        ---------------------------------------
                                        Anthony Broderick, Director

Dated: November 15, 1999                ----------------------------------------
                                        Evelyn Berezin, Director

Dated: November 15, 1999                *
                                        ---------------------------------------
                                        Charles McQuinn, Director

*By: /s/ Frank Mandelbaum
- --------------------------
      Frank Mandelbaum
      Attorney-in-fact

                                      II-8




                                                                   Exhibit 10.11


                           Memorandum of Understanding
                 Between AAMVAnet, Inc., and Intelli-Check, Inc.

 This Memorandum of Understanding ("MOU") is effective the 15th day of November
 1999, between AAMVAnet, Inc. ("AAMVA") and Intelli-Check, Inc. ("Laboratory")


PURPOSE
AAMVAnet  and the  Laboratory  strongly  believe  that the value of  interaction
between  AAMVAnet and the  Laboratory  can only  strengthen  their  programs and
further  develop the  relationships  between the two  entities as they work more
closely  together  and thus  better  understand  each  other  for this and other
potential future projects.

GENERAL UNDERSTANDING
AAMVAnet and the Laboratory  consider that both  organizations will benefit from
the interchange of ideas and practices.

AGREEMENT
AAMVAnet and the Laboratory agree to provide reasonable cooperation in a variety
of joint activities that shall include, but not limited to: A) the decoding
evaluation and testing of electronically readable media for specific
Jurisdiction Driver Licenses and Identification Cards ("ID's") either in
circulation or pending issuance. B) Joint research cooperation and criteria
development for Driver Licenses standards. C) Participation in seminars,
conferences, workshops, and other professional development activities. D) Both
organizations agree to make efforts, individually and in concert to secure
appropriate financing to support the activities contemplated in this MOU.
AAMVAnet agrees to reimburse the Laboratory the administrative costs for report
production and the shipping of said reports upon the Laboratory's submission of
invoice(s) supporting such administrative costs.

AAMVAnet  and the  Laboratory  agree to  exclusively  produce  joint  reports in
accordance  with the intent of this MOU.  Reports  may intend to  summarize  and
evaluate the  Jurisdictions  ability to conform to those standards  specified by
AAMVAnet.  If the need arises, each party shall attempt to prepare more detailed
joint  agreements  to  clarify  the  logistical  arrangements  for any  specific
activity  contemplated.  AAMVA  agrees to use its best  efforts  to  obtain  and
deliver to the  Laboratory,  when  possible,  all of the materials  necessary to
evaluate  the  encoding,   decoding,   encryption  and  decryption   testing  of
electronically readable media for specific Jurisdiction ID's.

For the purpose of this MOU,  both AAMVAnet and the  Laboratory  agree to permit
the reproduction and use of each other's  Trademarks,  Service Marks, Logo's and
indicia ("Mark") where and when applicable.  Each party further agrees that each
Report will clearly contain a statement of ownership  rights for each Mark used.
For example ("Intelli-Check is a Trademark of Intelli-Check, Inc.").

Both parties agree to distribute  these Reports only to parties directly related
to the production of each specific  Jurisdiction's ID's either in circulation or
pending issuance being tested. This would include  Manufacturers of the specific
Jurisdiction's  ID's and the  associated  government  agencies  of the  specific
Jurisdiction. Other desired distribution requires the written permission of each
party.

AAMVAnet and the Laboratory  agree to continue  discussions of particular  joint
projects  and  exchanges.  In the event that the parties  hereto wish to execute
future joint research or consulting  agreements,  such agreements  shall specify
the parties' potential exploitation of each other's intellectual property rights
including Patents,  Copyrights and Trademarks. Such agreements shall also define
the financial,

                                                                     Page 1 of 2

<PAGE>


legal, and other commitments of each party. Nothing in this MOU is intended to
effect, alter or amend either parties' legal rights or obligations with respect
to the other party and/or their intellectual property rights. This MOU shall
serve only as a magnification of each parties' desire to cooperate in joint
educational ventures and, if possible, to negotiate and execute valid and
legally binding obligations in the future.

DURATION
The  duration of this  agreement  shall be for one (1) year  beginning  from the
effective  date of the  agreement  and if  mutually  desired,  in one  (1)  year
increments thereafter. However, either party may terminate the agreement upon 30
days notice, so as to give any current testing sufficient time to conclude.  The
notice provision will not negatively  affect any testing in progress at the time
of the decision.

For the  duration of this  agreement  and a period of one (1) year  after,  Both
parties agree that each party will make its best efforts to protect each other's
confidential information. This agreement is exclusive in nature. During the term
of this  agreement and for the purposes  outlined in this MOU,  AAMVAnet  agrees
that it will use the Laboratory  exclusively  and the Laboratory  agrees that it
will exclusively supply this information to AAMVAnet.

IN WITNESS WHEREOF, this Memorandum of Understanding is entered into on the date
first above written.

AGREED TO BY:

AAMVA (AAMVAnet, Inc.)

      /s/ Jay Maxwell                                       11/10/99
- ------------------------------------                ---------------------------
Jay Maxwell, President                              Date:

THE LABORATORY (Intelli-Check, Inc.)

     /s/ Kevin Messina                                      11/11/99
- ------------------------------------                ---------------------------
Kevin Messina, President                            Date:






                                                                     Page 2 of 2




                                                                    EXHIBIT 23.2


                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

      As independent public accountants, we hereby consent to the use of our
report dated September 24, 1999 for Intelli-Check, Inc. included in or made a
part of this registration statement.

                                                             ARTHUR ANDERSEN LLP

New York, New York
November 15, 1999



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission